A Study of the Molecular Diversity of Staphylococcus aureus Plasmids and Their Role in the Characterisation of Methicillin-Resistant Staphylococcus aureus by Coia, John E
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
A STUDY OF THE MOLECULAR DIVERSITY OF 
STAPHYLOCOCCUS AUREUS PLASMIDS AND THEIR 
ROLE IN THE CHARACTERISATION OF METHICILLIN- 
RESISTANT STAPHYLOCOCCUS AUREUS
BY
JOHN E. COIA B.Sc. M.B. Ch.B.
being a thesis submitted for the Degree of Doctor of Medicine in 
the University of Glasgow, Faculty of Medicine, October 1990
©JOHN COIA 1990
1
ProQuest Number: 10983764
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10983764
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
To Bernadette, Wee John and Mum, who are simply the best, 
and deserve the real credit
TABLE OF CONTENTS
TITLE PAGE 1
TABLE OF CONTENTS....................................................   3
LIST OF TABLES.................................................................................... 7
LIST OF ILLUSTRATIONS................................................................... 9
ACKNOWLEDGEMENTS................................................................... 11
DECLARATION.....................................................................................12
SUMMARY..............................................................................................13
ABBREVIATIONS....................................................   18
1 INTRODUCTION...................................... ........................................23
MRS A in Scotland...........................................................................28
Mechanism of methicillin-resistance............................................... 29
Epidemiology of MRSA infection...................................................31
Traditional Methods............................................................... 32
Recent developments............................................................. 34
Proteins.................................................................................. 35
Nucleic acids.......................................................................... 37
Plasmid profiles..................................................................... 37
Restriction enzyme fragmentation patterns............................40
Chromosomal REFPs.........................................   43
DNA probes........................................................................... 44
Pathogenicity of Staphylococcus aureus..........................................47
Cell wall associated factors.................................................... 47
Extracellular products.............................................................48
Enzymes................................................................................. 48
Toxins.................................................................................... 50
Pathogenicity of MRSA...................................................................53
2 MATERIALS AND METHODS....................................................... 57
Bacterial Strains...................................  58
Methicillin-sensitive Staphylococcus aureus (MSSA)...........58
Methicillin-resistant Staphylococcus aureus (MRSA)...........58
Isolation and identification of organisms.........................................59
Antibiotic susceptibility testing....................................................... 59
Phage typing.....................................................................................60
Biotyping......................................................................................... 60
Preparation of immunoblots of exported proteins............................61
Determination of plasmid profiles................................................... 63
Preparation of purified plasmid DNA..............................................64
Restriction endonuclease digestion..................................................66
Enterotoxin production.....................................................................67
Detection of Haemolysins................................................................68
a-haemolysin..........................................................................69
4
P-haemolysin......................................................................... 70
y-haemolysin.......................................................................... 70
S-haemolysin.......................................................................... 70
Statistical analysis ...................................................................... 71
3 RESULTS............................................................................................ 72
Antibiotic susceptibility testing....................................................... 73
Antibiograms......................................................................... 73
Aminoglycoside-resistance.................................................... 74
Mupirocin-resistance............................................................. 74
Biotyping......................................................................................... 75
Immunoblotting............................................................................... 76
Plasmid profiles............................................................................... 77
Plasmid-bearing isolates........................................................ 77
Distribution of plasmids.........................................................77
Plasmid sizes.......................................................................... 78
Number of REFPs.................................................................. 79
MRSA isolates....................................................................... 79
MRSA(l).......................................................................79
MRSA(2)...................................................................... 81
MSS A isolates....................................................................... 82
Common features................................................................... 82
Small plasmids....................................................................... 83
Size heterogeneity.................................................................. 83
Comparison of biotyping, immunoblotting, REFPs and phage typing
of MRSA(l)................................................................. 84
Pathogenicity factors...............................................   85
Enterotoxin production...........................................................85
Distribution of individual enterotoxins...................................86
Enterotoxin A ................   86
Enterotoxin B ................................................................86
Enterotoxin C ............................................................... 87
Enterotoxin D ................................................................87
Distribution of enterotoxin-producing strains.........................87
Haemolysin Production..........................................................89
Distribution of individual haemolysins...................................90
a- haemolysin.......................  90
P- haemolysin................................................................91
y- haemolysin................................................................91
6- haemolysin............................................................... 92
Distribution of haemolysin-producing strains ...................92
4 DISCUSSION.......................................................................................94
Antibiotic resistance.........................................................................95
Prevalence and distribution of plasmids in MSS A AND MRSA 95
Comparison of MSSA and MRSA REFPs.......................................97
Origins of MRSA within GRI........................................................100
Comparison of characterisation of MRSA by biotyping,
immunoblotting and REFPS.......................................102
Pathogenicity factors......................................................................108
5
Enterotoxin production.............. .........................................108
MSS A isolates............................................................ 109
MRSA isolates........................................................... I l l
MRSA and MSSA compared...............   113
Haemolysins............................. .......................................... 114
MSSA......................................................................... 115
MRSA.........................................................................116
MRSA and MSSA compared......................................117
General considerations......................................................... 117
Future developments..................................................................... 119
5 CONCLUSIONS............................................................................... 126
APPENDIX 1 Origins, antibiotic sensitivities, number of plasmids
harboured and REFPs of Staph, aureus isolates.................... 129
APPENDIX 2 Phage-types of MRSA 154 -
APPENDIX 3 Enterotoxin and haemolysin production by Staph, aureus 
from different sources.......................................................... 157
REFERENCES...................................................................................... 175
6
LIST OF TABLES
Table I. Penicillin binding proteins (PBPs) of Staphylococcus aureus ....30 
Table II. Examples of palindromic restriction endonuclease enzyme
cleavage sites......................................................................... 41
Table III. Extracellular enzymes of Staphylococcus aureus.....................49
Table IV. Toxins of Staphylococcus aureus.............................................50
Table V. Numbers of isolates in each collection resistant to individual
antibiotics............................................................................... 73
Table VI. Distribution of resistance determinants in isolates from different
sources................................................................................... 74
Table VII. Distribution of MRSA antibiograms.......................................75
Table VIE. Biotypes of MRSA................................................................ 76
Table IX. Frequency distribution of plasmids in isolates from different
sources................................................................................... 77
Table X. Frequency distribution of plasmids in combined MSSA and
MRSA isolates compared.......................................................78
Table XI. REFP group, immunoblot group, biotype and phage type (RTD)
of MRSA(l)........................................................................... 84
Table XII. Distribution of enterotoxin production in isolates from
different sources..................................................................... 85
Table XIII. Comparison of numbers of enterotoxin producers and non­
producers amongst isolates from different sources.................88
Table XIV. Comparison of multiple enterotoxin production by isolates
from different sources.............................................................88
Table XV. Distribution of haemolysin production in isolates from
different sources......................................................................90
Table XVI. Comparison of numbers of haemolysin producers and non­
producers amongst isolates from different sources.................92
Table XVII. Comparison of multiple haemolysin production by isolates
from different sources.............................................................93
Table XVIII. Comparison of observed plasmid distributions in MSSA and 
MRSA with distributions predicted by a modified Poisson
model..................................................................................... 97
Table XIX. Distribution of enterotoxin production in isolates from
different sources - Dublin and Glasgow compared..............110
Table XX. Distribution of haemolysin production in isolates from
different sources - Dublin and Glasgow compared..............116
8
LIST OF ILLUSTRATIONS
Figure 1. Structure of methicillin and the isoxazolyl penicillins,
cloxacillin and flucloxacillin.................................................. 26
Figure 2. Comparison of the distribution of resistance determinants/isolate
of Staph, aureus from different sources.................................73
Figure 3. Typical immunoblots of MRSA culture supernates................. 76
Figure 4. Frequency distributions of plasmids in isolates from different
sources................................................................................... 78
Figure 5. Comparison of frequency distributions of plasmids in MSSA
and MRSA isolates................................................................ 78
Figure 6. Typical S. aureus plasmid profiles........................................... 79
Figure 7. Typical S. aureus plasmid profiles........................................... 79
Figure 8. Typical HaeTLI restriction patterns of S. aureus........................79
Figure 9. Typical HaeTLL restriction patterns of MRSA............................79
Figure 10. HaelTL restriction patterns of MRSA(l)................................. 79
Figure 11. HaeIII restriction patterns of MRSA(2)..................................81
Figure 12. Examples of HaeIII restriction patterns of S. aureus.............82
Figure 13. Typical HaeTLL restriction patterns of MRSA.........................82
Figure 14a. i /« I  restriction patterns of S. aureus.....................................83
Figure 14b. Alul restriction patterns of S. aureus.....................................83
Figure 15. Correlation of immunoblot, REFP group and biotype of
MRSA(l) isolates.................................................................. 84
Figure 16. Results of RPLA tests for enterotoxins of Staph, aureus.......85
Figure 17. Distribution of multiple enterotoxin production by Staph.
aureus from different sources.............................   89
Figure 18. Results of tests for haemolysins of Staph, aureus.................. 89
Figure 19. Distribution of multiple haemolysin production by Staph.
aureus from different sources...................   93
Figure 20. Restriction enzyme fragmentation patterns of two hypothetical
related plasmids (a) and (b)..................................................122
Figure 21. Pstl chromosomal fingerprints of Staph, aureus.................. 124
Figure 22a HaelTL restriction enzyme fragmentation patterns of Staph.
aureus; patterns (1-19)..........................................................130
Figure 22b HaeTLI restriction enzyme fragmentation patterns of Staph.
aureus; patterns (20-38)........................................................130
Figure 22c. HaeTLI restriction enzyme fragmentation patterns of Staph.
aureus; patterns (39-56)........................................................130
10
ACKNOWLEDGEMENTS
I would like to thank Professor Soad Tabaqchali and Dr Barry 
Cookson for providing EMRSA isolates, and Dr Brian Keighley 
for assistance in collecting community isolates. Special thanks to 
Drs Dugald Baird, Harry Birkbeck, David Platt and Morag 
Timbury for all their encouragement and assistance. Particular 
thanks to Professor Douglas Sleigh for all his advice and 
encouragement in the preparation of this work.
Final thanks to Sheila and Joseph Lynch for helping to check
this manuscript.
DECLARATION
The experiments and composition of this thesis are the work of 
the author unless otherwise stated.
12
SUMMARY
13
Two hundred and sixty-four isolates of Staphylococcus 
aureus were collected; 163 methicillin-sensitive Staph, aureus 
(MSSA) and 101 methicillin-resistant Staph, aureus (MRSA). 
MSSA comprised: from Glasgow Royal Infirmary (GRI) 50 blood 
culture isolates (BC), 63 isolates from routine diagnostic specimens 
(RD) and fifty strains from nasal swabs of patients attending a 
general practitioner (GP). The MRSA from GRI comprised: 53 
isolates from 1985-86 (MRSA(l)) and 48 isolates from 1986-87 
(MRSA(2)).
The number, frequency distribution and diversity of 
plasmids harboured by these strains was compared by means of 
plasmid profiles and restriction enzyme fragmentation patterns 
(REFPs). Plasmids were demonstrated in less than half the MSSA; 
their frequency distribution did not differ from that predicted by a 
simple model of plasmid distributions. In contrast, all MRSA 
harboured plasmids and their distribution differed significantly from 
the MSSA.
Among 71 MSSA harbouring plasmids, 38 REFPs were 
identified. There were fewer REFPs among MRSA isolates; 11 
MRSA(l) and 11 MRSA(2) patterns were observed, of which four 
were common to both collections. No MSSA patterns were 
identified amongst MRSA REFPs. The plasmid diversity of 
MRSA(l) and MRSA(2) isolates did not differ. Two predominant 
MRSA REFPs accounted for 70 % of those identified amongst 
MRSA and Dice analysis of all MRSA patterns defined two main
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subgroups, FP1 and FP2, which correlated with the presence or 
absence of aminoglycoside-sensitivity.
Two size groups of plasmids, large and small could be 
discerned amongst Staph, aureus isolates. In the MRSA the large 
plasmids comprised two main species and molecular variants 
thereof; large MSSA plasmids were more diverse, and did not occur 
in common between MSSA and MRSA. Small plasmids were 
present only in MRSA and MSSA isolates which harboured more 
than one plasmid. Such plasmids were represented by a single 
multicopy species of 2.6 kb, which yielded the same REFP 
irrespective of its source.
Forty-five MRSA(l) isolates were further characterised by 
means of phage typing, simple biotyping and immunoblotting of 
exported proteins. The strains were subdivided into four groups (A- 
D) on the basis of biotype. Immunoblotting generated a number of 
unique patterns which were separated by Dice analysis into two 
major immunoblot groups (Blotl and Blot2). Comparison of REFP 
and immunoblot groups revealed strong positive correlation between 
FP1 and Blotl groups and between FP2 and Blot2 groups. In 
addition B lotl/FPl isolates were almost exclusively of biotypes A  or 
C, whereas Blot2/FP2 isolates were of biotypes B or D.
Comparison of production of enterotoxins A, B, C and D, 
and a - ,  P-, y - and 6- haemolysins by MSSA and M RSA(l) isolates 
was performed by reverse passive latex agglutination (RPLA) and
15
agar overlay methods respectively. Sixty percent of BC MSSA 
produced enterotoxin; similar rates were found amongst other 
MSSA. Eighty-seven percent of aminoglycoside-sensitive MRSA 
produced enterotoxin; 89 % enterotoxin A  alone. Only 27 % of 
aminoglycoside-resistant MRSA were enterotoxin-positive; 
significantly less than either MSSA or aminoglycoside-sensitive 
MRSA.
The proportion of haemolysin producing isolates did not 
differ amongst MSSA and MRSA; unlike enterotoxin production 
there was no difference in the distributions of haemolysins between 
aminoglycoside-sensitive and resistant strains of MRSA. GP MSSA 
had higher and lower numbers of y- and 6- haemolysin producers 
respectively than other Staph, aureus, a -  haemolysin producers 
were commoner amongst MRSA isolates, which also were more 
likely to produce multiple haemolysins than their methicillin- 
sensitive counterparts.
Information derived from plasmid distributions, REFP 
analysis, biotyping, immunoblot analysis and enterotoxin data were 
all compatible with a hypothesis of dissemination of a limited 
number of MRSA clones within GRI. The ubiquity of small plasmid 
species amongst MSSA and MRSA isolates raises the possibility 
that such clones may have arisen locally amongst endogenous 
methicillin-sensitive strains. The use of a combination of methods 
as described here has provided comprehensive epidemiological
16
information which has been valuable in studying the origin and 
spread of MRSA.
17
ABBREVIATIONS
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AMBIS Automated bacterial 
identification system
BC Blood culture isolates of 
Staph, aureus
BIO A MRSA biotype A
BIO B MRSA biotype B
BIO C MRSA biotype C
BIO D MRSA biotype D
Blotl MRSA immunoblot 1
Blot2 MRSA immunoblot 2
Blot3 MRSA immunoblot 3
C Chloramphenicol
Cn Gentamicin
CPHL Central public health 
laboratory, Colindale
Da Clindamycin
DNA Deoxyribonucleic acid
EDTA Ethylene-diamine-tetra- 
acetic acid
EMRSA Epidemic methicillin- 
resistant Staph, aureus
Ery Erythromycin
ETA Staph, aureus 
epidermolytic toxin A
ETB Staph, aureus 
epidermolytic toxin B
Fd Fusidic Acid
FP1 MRSA restriction enzyme 
fragmentation pattern 
group 1
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FP2 MRSA restriction enzyme 
fragmentation pattern 
group 2
FP3 MRSA restriction enzyme 
fragmentation pattern 
group 3
FP4 MRSA restriction enzyme 
fragmentation pattern 
group 4
GP Community isolates of 
Staph, aureus
GRI Glasgow Royal Infirmary
IgG Immunoglobulin G
Km Kanamycin
Met Methicillin
MRSA Methicillin-resistant Staph, 
aureus
MRSA(l) MRSA isolates collected 
between February 1985 
and April 1986
MRSA(2) MRSA isolates collected 
between May 1986 and 
July 1987
MRSA(R) Aminoglycoside-resistant
MRSA
MRSA(S) Aminoglycoside-sensitive
MRSA
MSSA Methicillin-sensitive Staph, 
aureus
Mup Mupirocin
P Penicillin
PBP Penicillin binding protein
PBS Phosphate-buffered saline
Rc Critical radius of inhibition
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RD Routine diagnostic isolates 
of Staph, aureus
Rd Rifampicin
rDNA DNA encoding ribosomal 
genes
REFP Restriction enzyme 
fragmentation pattern
RNA Ribonucleic acid
RPLA Reverse passive latex 
agglutination
rRNA Ribosomal ribonucleic acid
RTD Routine test dilution
SD Dice co-efficient of 
similarity
SDS Sodium dodecyl sulphate
SDS-PAGE Sodium dodecyl sulphate 
polyacrylamide gel 
electrophoresis
SET-RPLA Staphylococcal enterotoxin 
reverse passive latex 
agglutination test
Sm Streptomycin
TE a solution containing 
10 mM Tris and 1 mM 
EDTA, pH 8.0
Tec Teicoplanin
TES a solution containing 
50 mM Tris, 50m M N aC l 
and 5 mM disodium 
EDTA, pH 8.0
TESS TES containing 50 mM 
sucrose
Tet Tetracycline
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TSST-1 Toxic shock syndrome
toxin 1
V/cm Volts per centimetre
v/v Volume per volume
Va Vancomycin
W Trimethoprim
w/v Weight per volume
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CHAPTER 1
Introduction
23
Forty years after the introduction of effective antimicrobial 
chemotherapy, pyogenic infections due to Staphylococcus aureus 
remain a significant cause of morbidity and mortality, both within 
the hospital environment and the community at large. The spectrum 
of disease produced by these organisms is very wide, ranging from 
superficial skin lesions to severe systemic infections (Shanson, 
1986). The range of pathogenic processes which may be involved is 
almost uniquely wide, encompassing classical toxin mediated 
phenomena through direct tissue destruction to secondary immune 
mechanisms (Adlam and Easmon, 1983). The increasing numbers 
of nosocomial infections caused by Staph, aureus, especially those 
strains which are resistant to multiple antibiotics, will continue to 
present a major problem for all of those involved in the control and 
treatment of infection.
Staphylococci are non-motile, catalase-positive facultative 
anaerobes which grow in irregular clusters (Baird-Parker, 1972; 
Oeding, 1983). The demonstration of free coagulase and heat-stable 
deoxyribonuclease are the key tests for the differentiation of Staph, 
aureus from other staphylococci (Bergey's Manual, 1974). Hajek 
and Marsalek (1971) described six biotypes (A-F) of Staph, aureus, 
a classification supported by the results of Devriese and Oeding 
(1976); essentially those Staph, aureus isolates which are pathogenic 
for man belong to biotype (A) (Oeding, 1983).
The pathogenic potential of staphylococci has been 
recognised for over a century, since Sir Alexander Ogston first
24
described their causal role in the production of acute abscesses and 
septicaemia (Ogston, 1881). Nonetheless, in the pre-antibiotic era 
the prognosis for patients with severe staphylococcal disease was 
extremely poor. The introduction of penicillin into clinical use in 
the 1940s represented a dramatic breakthrough in the therapy of 
staphylococcal infections and transformed the previously dismal 
outlook for invasive and deep-seated disease (Plorde and Sherris, 
1974). However, this triumph was short-lived; the history of the 
emergence of resistance in Staph, aureus provides a paradigm for 
the interaction between pathogenic microorganisms and 
antimicrobial agents. Penicillin-resistant B-lactamase producing 
strains, initially described by Spink (Spink and Ferris, 1945), rapidly 
became widespread and by 1946 constituted some 60 % of hospital 
isolates of Staph, aureus in the United Kingdom (Barber, 1947; 
Barber and Rozwadoska-Dowzenko, 1948). The successive 
introduction of streptomycin, tetracycline, chloramphenicol, and the 
macrolides were all followed by the emergence of resistant 
organisms (Plorde and Sherris, 1974; Shanson, 1981). Most of the 
strains which were resistant to these new agents continued to 
synthesise a B-lactamase, and the emergence of multiply-antibiotic- 
resistant Staph, aureus presented a significant health care problem 
during the 1950s. Amongst these strains were those belonging to the 
notorious phage type 80/81, which in addition to their multiple 
antibiotic resistance demonstrated particularly enhanced 
pathogenicity and communicability, often causing severe cutaneous
25
sepsis on the unbroken skin of attending medical and nursing staff 
(Rountree, 1978; Shanson, 1981; Parker, 1983).
The advent of methicillin, and the penicillinase-resistant 
semisynthetic isoxazolyl penicillins, once again provided the means 
with which to counter the rising tide of nosocomial staphylococcal 
infection (Knudsen and Rolinson, 1960; Knox, 1960). Due to the 
renal toxicity of methicillin (Baldwin et al, 1968) and the 
requirement for parenteral administration, it was quickly superseded 
in clinical practice by other similar drugs, particularly cloxacillin 
and flucloxacillin (Figure 1) which remain to this day the mainstay 
of therapy for Staph, aureus infections.
However, within months of the introduction of methicillin 
into clinical practice, methicillin-resistant1 strains of Staphylococcus 
aureus (MRSA) were reported in Britain (Barber, 1961; Jevons, 
1961). In the subsequent 10 years these strains became quite 
widespread, particularly in some hospitals in the UK and Europe. 
(Parker and Hewitt, 1970; Kayser and Mak, 1972). Prevalences of 
the organisms varied between 1-2 % in some countries to 20 % and 
above in others. However, their prevalence declined in the early 
1970s for reasons which remain largely unexplained (Jepsen, 1986). 
For example between 1971 and 1975 the incidence of staphylococcal 
infections caused by MRSA in Zurich hospitals decreased from
^ethicillin-resistance is in fact a misnomer, as the resistance 
encompasses most, if not all, 6-lactam antibiotics.
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CONH
Methicillin
CONH
Cloxacillin
H COOH
CONH
H COOH
Flucloxacillin
Figure 1. Structure of methicillin and the isoxazolyl penicillins, 
cloxacillin and flucloxacillin.
20 % to 3 %, during which time the use of isoxazolyl penicillins and 
cephalosporins had remained unrestricted (Kayser, 1975).
Since the late 1970s there has been a marked resurgence of 
MRSA, with many isolates resistant to multiple antibiotics, 
including the aminoglycosides. They have been responsible for 
significant outbreaks of nosocomial infection world-wide (Marples 
and Cooke, 1988), especially in Australia (Pavillard et al, 1982; 
Turnidge et al, 1989), North America (Locksley et al, 1982) and 
more recently in many parts of Europe, including Ireland (Cafferkey 
et al, 1985; Morgan and Harte-Barry, 1989) and Great Britain 
(Cooke et al, 1986, Marples, 1988). In addition significant numbers 
of isolates have been reported from a number of other countries, 
including Greece, France, Portugal, Italy and the Middle East 
(Casewell, 1986; Marples, 1988; Maple et al, 1989).
These new MRSA have been shown by a variety of 
techniques, ranging from phage-typing to complex genetic analyses 
to differ from their predecessors (Townsend et al, 1985b; Vickery et 
al, 1986). What is perhaps more interesting is that in contrast with 
the "old" MRSA where there was evidence of a common clonal 
origin (Lacey and Grinstead, 1973), a number of studies have now 
shown significant differences can also occur between strains from 
different areas (Grubb et al, 1985; Marples et al, 1986; Townsend et 
al, 1987; Jordens and Hall, 1988; Carroll et al, 1989). This suggests 
that whilst the global spread of a single MRSA clone and its 
derivatives may occur (Humphreys et al, 1990), the present problem
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may additionally reflect the local evolution de novo of MRSA at 
multiple sites due to similar selection pressures acting upon 
endogenous methicillin-sensitive strains.
MRSA IN SCOTLAND
Few MRSA were seen in Scotland before 1984. An initial 
report by Barrie in Kirkcaldy of 12 isolations of MRSA from clinical 
infections during 1975 (Barrie, 1976), prompted a request from the 
Communicable Diseases Scotland Unit (CDS) for information from 
other laboratories. This study showed that MRSA were mainly 
present in three centres; Fife, Dumfries Royal Infirmary (where 
MRSA accounted for 7 % of Staph, aureus isolates), and Edinburgh 
Royal Infirmary. The majority of these isolates were phage type 77 
(CDS, 1977). By 1981 MRSA were reckoned to account for 1 % of 
all Staph, aureus isolates in Scotland (White, 1982). A  postal 
survey in 1983 by the Hospital Infection Society revealed that 
MRSA accounted for between 1 and 4 % of Staph, aureus in 
Scottish hospitals, a figure similar to that found in the rest of the 
United Kingdom (Cooke et al, 1986).
These initial Scottish MRSA have largely been superseded 
by other MRSA, which demonstrate variation from their earlier 
counterparts in a number of properties, including antibiogram, 
biotype and phage type. In the West of Scotland the majority of 
strains appear similar to, or to be derived from, MRSA first isolated 
in Glasgow Royal Infirmary (GRI), whereas in other parts of the
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country a diversity of strains has been found. In the first report of 
the Scottish MRSA Study Group, established in July 1986, isolates 
from GRI accounted for 119 of the 214 MRSA reported (Scottish 
MRSA Study Group, 1987). The GRI isolates appeared initially as 
two groups: aminoglycoside-sensitive MRSA derived from the 
Dermatology wards, and aminoglycoside-resistant MRSA from the 
Regional Burns Unit. The second Study-group report still showed 
the majority of MRSA to have been isolated in Glasgow, but with an 
increasing number of reports from other areas, particularly those 
with a major tertiary referral centre (Scottish MRSA Study Group, 
1988). In the period from the start of 1984 until the end of 1989, 
there were reports of isolation of MRSA from 1275 patients, with 
only two of the fifteen health boards remaining MRSA-free. Of 
these isolations, 732 were from GRI, where MRSA continue to 
account for around 4 % of all Staph, aureus isolations (D R Baird, 
personal communication).
MECHANISM OF METHICILLIN -RESISTANCE
The B-lactamase stable penicillins and cephalosporins exert 
their action in a similar way to penicillin G. Carboxypeptidase and 
transpeptidase enzymes which are essential to cell wall 
peptidoglycan synthesis are covalently bound and therefore inhibited 
(Hammond and Lambert, 1981). Studies of these enzymes, which 
are collectively referred to as penicillin-binding proteins (PBPs) in 
Staph, aureus have demonstrated four or five distinct species (Table 
I) (Wyke, 1984; Canepari et al, 1985).
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Table I. Penicillin binding proteins (PBPs) of Staphylococcus aureus
PBP Molecular weight
PBP1 79,000-87,000
PBP2 73,000-80,000
PBP3 70,000-75,000
PBP3' 70,000
PBP4 41,000-46,000
In contrast to resistance to penicillin G, which is due to 
degradation of the antibiotic by a bacterial B-lactamase, resistance to 
methicillin is intrinsic and is mediated by means of the synthesis of 
an altered PBP (2’ or 2a) of molecular weight 74,000-78,000 which 
has a greatly reduced affinity for B-lactam antibiotics (Lyon and 
Skurray, 1987). Methicillin-resistance is encoded by the mec gene 
which is chromosomally located, as determined by successful 
transformation of resistance by chromosomal, but not by plasmid, 
DNA (Sjostrom et al, 1975). The chromosomal location of this 
determinant has been genetically mapped (Kuhl et al, 1978). The 
control of expression of this element is complex, involving both an 
additional distinct chromosomal locus and regulation by a B- 
lactamase determinant (possibly mediating an effect via the blal B- 
lactamase repressor gene). In addition, the observed decreased PBP 
2’ expression in acidic conditions and increased expression at 32°C, 
coupled with the thermolability of the protein, help explain the 
characteristic heterogeneous nature of methicillin-resistance in 
clinical isolates of Staph, aureus (Lyon and Skurray, 1987).
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EPIDEMIOLOGY OF MRSA INFECTION
The study of the origin and spread of a microorganism 
requires an adequate typing method, and a number have been 
described to study the epidemiology of MRSA. Before considering 
some of these methods in more detail, it is perhaps worth 
considering some of the factors involved in the evaluation and 
comparison of typing strategies. The key elements of a typing 
system are typability, reproducibility and discrimination. Typability 
and reproducibility are reasonably straightforward to assess: 
typability is simply the percentage of distinct bacterial strains which 
can be assigned a positive typing marker by the method, and 
reproducibility is the percentage of strains which yield the same 
result on repeated testing. Discrimination however, is determined 
both by the number of discrete types defined and the relative 
frequencies with which these are detected in the population under 
study. Although Hunter and Gaston (1988) have suggested the 
adoption of a discriminatory index derived from these two 
parameters, based on Simpson's Index of diversity, objective 
assessments of the discriminatory ability of a typing system have not 
been widely adopted.
There are other factors which serve to confound objective 
comparisons of typing systems. Although apparently similar 
methods may be employed at different centres, there are often 
significant, and sometimes undisclosed, variations in technique 
which limit the comparability of the data generated. In addition,
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typing methods are often developed to address specific local 
problems, and as a result may reflect the properties and behaviour of 
local isolates. Even in the local context, there is an understandable 
tendency to concentrate on isolates of interest, such as ’’epidemic” 
strains, without fully assessing the characteristics of the 
"background” population of the same organism.
Clearly, the introduction of any method for widespread use 
requires careful standardisation and validation in suitable 
representative collections of the organism. To justify the initial 
outlay any new method must demonstrate a significant advantage, 
by providing more useful information, faster results, or a saving in 
resources.
Traditional Methods
Phage typing has been employed for more than 40 years as 
the routine method to study the epidemiology of infection with 
Staph, aureus. Fisk (1942a, 1942b) was the first to show that Staph, 
aureus carried phages which could be detected by cross-culture of 
pairs of strains and propagated on the sensitive member of the pair 
by strain-specific lysis. Wilson and Atkinson (1945) subsequently 
established a set of phages for the classification of Staph, aureus, 
and in 1953 an International Subcommittee was formed to 
standardize the methodology. Since that time the method has been 
extensively developed and, although originally important as a means 
of distinguishing between strains of staphylococci in small short­
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lived local epidemics, has been of immense value in the study of 
national and indeed international trends in the spread of 
staphylococcal infections (Parker, 1983). Perhaps the best known 
example of this latter phenomenon was the identification and 
documentation of the subsequent spread of the uniquely pathogenic 
strains belonging to phage type 80/81 (Parker, 1983).
Unfortunately the application of phage typing to the study of 
MRSA has been rather disappointing. The original MRSA strains of 
the 60s and 70s had a variety of phage-typing patterns (Parker and 
Hewitt, 1970) in spite of genetic evidence to suggest a common 
clonal origin (Lacey, 1972; Lacey and Grinsted, 1973), probably 
reflecting their variable lysogenic state. However, of more concern 
is the fact that many of the MRSA strains encountered at present are 
poorly typed by the current International Set of phages (Marples et 
al, 1986; Marples, 1988; Richardson et al, 1988). In addition, it has 
been demonstrated previously that the typability of epidemic strains 
of Staph, aureus may decrease with time (Jevons and Parker, 1964); 
such a phenomenon has been described for EMRSA isolates 
(Marples et al, 1986). Although the use of supplementary phages 
may increase the number of typable strains (Vickery et al, 1986; 
Richardson et al, 1988), it has become clear that phage-typing alone 
is inadequate for the investigation of outbreaks of MRSA infection.
Other traditional approaches to staphylococcal 
epidemiology have included resistotyping (Elek and Moryson, 1974) 
in which strains are differentiated according to their degree of
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resistance to a variety of chemicals and antibiotics and their biotype. 
Resistotype tests, particularly for resistance to heavy metals, are 
often used now to detect plasmid-encoded phenotypic markers 
(Emslie et al, 1985; Townsend et al, 1985a). Antibiograms alone do 
not tend to produce sufficiently detailed discrimination for 
epidemiological purposes. However, a typing system proposed 
recently for MRSA uses antibiotic-sensitivity test results in 
conjunction with sensitivity to various chemicals and this shows 
some promise for routine application (Gillespie et al, 1990). 
Cookson et al (1986) have described a biotyping system for MRSA 
based upon a modification of the technique of Andrew and Symons 
(1982). This system tests a- and B-haemolysin production, 
proteolysis, pigmentation, Tween 80 hydrolysis, lipase and 
lecithinase production, and was found to be useful in the initial 
screening of MRSA isolates. Simple biochemical tests (Peacock et 
al, 1981; Vickery et al, 1988) and pigmentation (Lacey and Stokes, 
1979) appear to be of limited value only, in strain discrimination.
Recent developments
In recent years a great deal of attention has focussed on the 
application of modern biochemical and molecular biological 
techniques to the study of the epidemiology of the agents of 
infectious disease. The use of such methods in this context has been 
reviewed recently (Goldmann, 1987; Hawkey, 1987). In essence, all 
of these methods separate large organism-derived biological 
macromolecules by gel electrophoresis to yield a pattern which is
34
characteristic of the strain; they differ in the nature of the analyte, 
which may be protein, plasmid or nucleic acid fragment, and the 
means of demonstrating the resulting patterns.
Proteins
Branger and Goullet (1987, 1989) characterised MRSA by 
means of the polymorphism of esterase enzymes. The enzymes 
were separated by means of polyacrylamide agarose gel 
electrophoresis. The esterases were subsequently "stained" in the 
gel by means of their interaction with a variety of synthetic 
substrates. Depending upon the pattern of activities demonstrated, 
and their selective inhibition by various substrate analogues, they 
were able to assign isolates from different countries and outbreaks to 
one of a number of distinct zymotypes. Again, their results 
supported the hypothesis that there had been global spread of some 
MRSA types, whereas others had evolved locally. Some zymotypes 
were unique to specific locations, and others belonged to the same 
type as local methicillin-sensitive strains. Although excellent 
reproducibility, typability and discrimination were possible, the 
procedure was both lengthy and technically complex.
Analysis of whole-cell protein profiles of MRSA generated 
by sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) has also been used to study the epidemiology of 
MRSA infection. However, whether performed by semi-automated 
densitometric examination of 3 5 S-methionine labelled polypeptides
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in an automated bacterial identification system (AMBIS), or 
manually by means of Coomassie-blue stained preparations, 
discrimination of different strains was poor (Stephenson et al, 1986; 
Thomson-Carter and Pennington, 1989).
Burnie and Matthews (1987) first suggested the use of 
Western blot analysis of whole-cell polypeptides as a typing method 
for bacterial pathogens. Polypeptides are separated by means of 
SDS-PAGE and "blotted" onto nitrocellulose filters (Towbin et al, 
1979). They are then "probed", usually with hyperimmune rabbit 
antisera raised against the pathogenic microorganism. After 
washing, specifically bound antibodies are detected by the 
application of anti-rabbit globulin conjugated to a fluorescent or 
enzymatic marker which enables the antigenic polypeptide bands to 
be demonstrated. Recognition of antigenic variation within a subset 
of the total polypeptide bands present permits greater discrimination 
than SDS-PAGE analysis alone. This technique has been applied 
successfully to a range of microorganisms including Candida 
albicans, coagulase-negative staphylococci and Clostridium difficile 
(Lee et al, 1986; Burnie et al, 1988; McKay et al, 1989). MRSA 
can be typed successfully by this method (Lee and Burnie, 1988), 
and good correlation has been shown with the results of a variety of 
other methods including phage-typing, plasmid profile analysis and 
restriction enzyme digestion of chromosomal DNA (Gaston et al, 
1988; Burnie et al, 1989).
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Nucleic acids
The genetic basis of antibiotic resistance in staphylococci 
has long been a subject of interest, speculation and intensive 
research activity by microbiologists (Lacey, 1972, 1975; Shalita et 
al, 1980). It is hardly surprising that the application of modern 
molecular techniques has resulted in an enormous increase in 
information about these processes. This work has been reviewed 
recently in some detail by Lyon and Skurray (1987). The analysis of 
chromosomal and extrachromosomal DNA has also been an 
excellent research method for the molecular epidemiologist (Platt, 
1983).
Plasmid profiles
Plasmids are circular molecules of supercoiled DNA which 
exist independently of the main chromosome within the cytoplasm 
of the bacterial cell. They are capable of autonomous replication 
and segregate during the process of cell division, to become 
partitioned within the daughter cells. Plasmids have been identified 
in virtually all bacterial genera. The number of copies of any given 
plasmid in a single cell varies, and may be as many as 40 for small 
plasmids, or as few as one if the plasmid is large. A variety of 
phenotypic traits may be encoded by plasmids: of greatest clinical 
importance is antibiotic resistance. In general plasmid-encoded 
traits are not essential for host survival, although they may confer 
selective advantages upon the organism. However, the function of 
the majority of plasmids remains unknown; these are termed cryptic
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plasmids (Broda, 1979; Novick, 1980). Different plasmid species 
may co-exist within the same cell, but related plasmids tend to be 
incompatible, and such incompatibility provides the basis of a means 
of classification (Datta, 1977). Staphylococcal plasmids can be 
exchanged between organisms by bacteriophage transduction, 
transformation and processes analogous to conjugation (Lyon and 
Skurray, 1987). In addition inter-species transfer of plasmids has 
been demonstrated, for example between Staph, aureus and 
coagulase-negative staphylococci (Forbes and Schaberg, 1983). The 
relative importance of these various phenomena in vivo is poorly 
understood.
Until about 10 years ago, the prolonged and complicated 
procedures for the detection and preparation of plasmid DNA, which 
required large culture volumes and density-gradient centrifugation, 
precluded the widespread application of plasmid analysis as an 
epidemiological tool in medical microbiology. However, the advent 
of rapid, simple techniques for the isolation of plasmid DNA 
provided a method for the analysis of large. numbers of clinical 
isolates. (Birnboim and Doly, 1979; Platt and Sommerville, 1981). 
The number and size of plasmids harboured by a given bacterial 
strain, can be demonstrated by agarose gel electrophoresis of the 
extracted plasmid DNA and staining with the intercalating dye 
ethidium bromide; this is referred to as a plasmid profile. It is the 
comparison of such plasmid profiles from a series of isolates which 
provides the basis of a typing scheme for use in epidemiological
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studies. It is obvious that if an isolate is plasmid-free, it cannot be 
typed by this method, and if certain plasmids are present invariably 
in all isolates of an organism, the value of those plasmids as 
epidemiological markers is correspondingly diminished. For these 
reasons when developing a typing scheme it is necessary at the 
outset to determine the relative abundance and distribution of 
plasmids within collections of organisms representative of the 
population to be studied (Platt et al, 1984,1986a). Plasmids interact 
with their host organisms in a dynamic way and as a result may be 
lost, gained and undergo molecular rearrangement (Hawkey, 1987). 
The stability of any given plasmid species depends on two major 
conflicting factors: the benefits for the survival of the host organism 
conferred by properties encoded by the plasmid, balanced against 
the disadvantages imposed by the biosynthetic burden due to its 
continued carriage.
Plasmid profile analysis has been successfully employed in 
studies of the epidemiology of infection with a range of Gram- 
negative and Gram-positive bacteria (Farrar, 1983; John et al, 1983; 
Schaberg and Zervos, 1986). The technique has been of particular 
value in the study of outbreaks of salmonellosis (Taylor et al, 1982; 
Threlfall et al, 1986) and coagulase-negative staphylococcal 
infection (Archer et al, 1984). Various groups have employed the 
method as part of their investigation of the epidemiology of MRSA 
infection (Cookson et al, 1986; Gelmi et al, 1987; Rhinehart et al, 
1987; Gaston et al, 1988), although in all but one case (Rhinehart et
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al, 1987) plasmid profile data alone was of limited value, due to the 
frequent finding of isolates with similar plasmid profiles, and 
plasmids of similar molecular weights. None of these studies 
attempted to compare the plasmid profiles of MRSA with those of 
methicillin-sensitive strains present in the same environment.
Restriction enzyme fragmentation patterns
Plasmids of similar size can often be difficult to differentiate 
by means of plasmid profiles alone. Agarose gel electrophoresis is 
also relatively inaccurate in determining the size of large plasmids 
(Hawkey, 1987). To solve these problems it is necessary to develop 
a method which can differentiate plasmid species, especially when 
they are of similar molecular size. Diversity depends ultimately on 
variations in the DNA sequences of the plasmids, and the technique 
to be employed must be able to demonstrate such differences in base 
sequences.
Type II restriction endonucleases are enzymes which 
recognise specific, palindromic sequences in double stranded DNA 
molecules, probably by virtue of the tertiary structure of the 
molecules comprising the sequence, and catalyse the hydrolysis of 
the DNA strands at sites usually a few bases apart (Table II) (Platt, 
1983; Hawkey, 1987). When plasmid DNA is subjected to 
restriction endonuclease digestion a characteristic series of linear 
DNA fragments, ultimately determined by the DNA sequence of the 
plasmid, is produced. Separation of these fragments by agarose gel
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electrophoresis and staining with ethidium bromide produces a 
characteristic restriction enzyme fragmentation pattern (REFP) or 
"fingerprint"2 (Platt, 1983).
Table II. Examples of palindromic restriction endonuclease enzyme
cleavage sites
Producer organism Enzyme Base sequence
Escherichia coli EcoRl 5'-GiAATTC-31 
3 1-CTTAAfG-51
Bacillus globigii BgR 5 !-GCCNlNNNNGGC-31 
3 1-CGGNNNNfNCCG-51
Bgm s ' - a I gatct- s 1
3 ’-TCTAGfA-51
Haemophilus influenzae Hindlll 5 1-AjAGCTT-31 
3 !-TTCGAfA-51
Serratia marcescens Smal 5'-CCClGGG-3' 
3 1-GGG|CCC-51
N = any nucleotide 
t  and J indicate site of hydrolysis
Ideally, the number of fragments generated should be 
sufficient for specificity, but production of an excess should be 
avoided so that coincidental matching of bands does not take place. 
Comparison of REFPs generated by a second different restriction 
enzyme is usually sufficient to confirm the identity of a pair of
2Fingerprint in this context should not be confused with the forensic 
technique of DNA fingerprinting. This latter technique for detection of 
restriction fragment length polymorphisms (RFLPs) is analogous, but only 
a subset of fragments is visualised as a result of hybridisation of probe 
DNA subsequent to Southern blotting of test DNA fragments to 
nitrocellulose membranes.
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plasmids thought to be identical on the basis of initial matching 
REFPs. Unfortunately standardised restriction enzyme digestion 
strategies which would facilitate comparison of plasmid data from 
different centres have not yet been adopted widely (Platt et al, 
1986b).
The application of this method is extremely powerful in 
studying the epidemiology of infections. John et al (1983) were able 
to show that two episodes of Klebsiella pneumoniae cross infection 
on separate wards in the same hospital, due to strains which all 
harboured a large (170 kb) plasmid, were unrelated because there 
were differences in the REFPs of the plasmids. The techniques have 
been applied very widely to a number of bacterial species, including 
some for which no previous typing schemes existed including 
Citrobacter diversus, Legionella pneumophila and Enterobacter 
cloacae (Goldmann, 1987; Hawkey, 1987).
In the study of MRSA, REFP analysis of plasmid DNA has 
been used to investigate the evolution and spread of a number of 
resistance plasmids (Dowd et al, 1983; Townsend et al, 1984, 
1985a, 1985b; Kayser et al, 1986; Lyon and Skurray, 1987). 
Furthermore, the molecular epidemiology of various MRSA 
outbreaks has been analysed by this method; REFP typing compares 
favourably with other methods (Gelmi et al, 1987; Rhinehart et al, 
1987; Gaston et al, 1988).
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Chromosomal REFPs
Although plasmid REFP analysis is a powerful tool for 
epidemiological studies, it suffers from the important limitation that 
the isolates under investigation must harbour plasmids, and that they 
must be stable and sufficiently diverse. Furthermore, the analysis of 
isolates which carry many plasmids can be difficult, and may 
sometimes require the prior segregation of plasmids. These 
problems can be avoided by preparing REFPs of chromosomal 
DNA.
The chromosomal DNA sequence found in different strains 
of the same organism will vary to some extent as a result of DNA 
rearrangements: these involve a variety of legitimate and illegitimate 
recombination events including deletions, duplications, inversions 
and transpositions. Thus, in a manner analogous to plasmid REFPs, 
digestion by restriction endonucleases should yield a unique series 
of linear DNA fragments, which will produce a characteristic pattern 
for that strain after agarose gel electrophoresis and ethidium bromide 
staining. These chromosomal REFPs have been employed for 
typing a variety of bacteria including Legionella pneumophila (Van 
Ketel et al, 1984), Neisseria meningitidis (Bjorvatn et al, 1984), 
Campylobacter jejuni (Bradbury et al, 1984) and Helicobacter 
pylori (Langenberg et al, 1986). Again, the technique has been used 
to study the epidemiology of MRSA infection (Jordens and Hall, 
1988), and was found to compare favourably with data derived from 
immunoblotting (Burnie et al, 1989).
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Compared with plasmid DNA chromosomal DNA is always 
present and is relatively stable, yet the technique lacks the 
refinement of plasmid analysis. The main difficulties are the very 
large number and range of sizes of fragments generated by 
restriction endonuclease digestion of chromosomal DNA. These 
fragments are difficult to resolve, coincidental matching of 
fragments of similar size is more likely to occur, and small 
differences are easily overlooked during visual inspection. In 
addition, if plasmid DNA is present, this may have unpredictable 
effects on the chromosomal REFP. Improved automated scanning 
techniques utilising laser or ultra-violet densitometry, coupled with 
microcomputer analysis, should help resolve some of these 
difficulties (Hawkey, 1987). More refined methods of 
electrophoresis using field inversion and pulse techniques may 
improve fragment resolution and facilitate the study of fragments in 
more discrete size ranges.
DNA probes
DNA probes are single-stranded DNA molecules, which can 
be labelled by radiometric or non-radiometric means, and which can 
hybridise with complementary nucleic acid sequences in test 
samples of DNA. If such a probe is applied to restriction 
endonuclease digested DNA fragments which have been transferred 
to nitrocellulose filters by the "blotting" technique of Southern 
(1975), it will hybridise with those fragments which contain 
sequences complementary to those of the probe. As a result these
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fragments may be visualised by autoradiography or 
colourimetrically if the non-radiometric biotin-avidin system is used 
(Hawkey, 1987).
Probes have been employed in two main ways to investigate 
epidemiological problems. Firstly, probes for specific genes 
characteristic of the test organism may be synthesised; examples 
include toxin or antibiotic inactivating enzyme genes. These probes 
can be used to identify the chromosomal restriction enzyme digest 
fragment on which the gene is harboured. A  study of variations in 
the fragments which bear the gene in different strains provides a 
useful epidemiological marker. This technique has been used to 
study the epidemiology of infections due to Vibrio cholerae and 
enterotoxigenic strains of Escherichia coli (Wachsmuth, 1986). In 
an analogous manner, families of probes may be synthesised for a 
given organism, representing a variety of chromosomal genes and 
differences in the patterns obtained after hybridisation compared 
(Hawkey, 1987). A  DNA probe derived from the PBP 2A gene of 
MRSA has been used to detect methicillin-resistance by means of 
dot-blot filter hybridisation (Archer and Pennell, 1990).
The second, and more generally applicable technique, is to 
prepare probes which will hybridise with sequences which are 
widely conserved across bacterial genera, and which occur in 
multiple copies on the bacterial chromosome. An example of a set 
of genes satisfying these criteria in bacteria are the genes encoding 
ribosomal RNA (rRNA). Following restriction endonuclease
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digestion, agarose gel electrophoresis, and Southern blotting as 
described above, DNA fragments carrying rRNA genes (rDNA) can 
be demonstrated by using a labelled Escherichia coli 16 + 23S 
rRNA probe. The probe will hybridise with multiple fragments, and 
variations in the underlying DNA sequence of the strains analysed 
will be reflected in different fragment patterns (Grimont and 
Grimont, 1986). In some respects this process is analogous to 
forensic human DNA fingerprinting, which uses the variation of 
restriction fragment lengths bearing highly conserved and highly 
repeated "minisatellite" sequences in a similar manner, to determine 
the genetic identity/non-identity of individuals (Gill et al, 1985).
This is a technique of great potential in epidemiology. 
Since the probe sequence is widespread amongst all bacterial genera, 
a single probe/set of probes, can be used to type a huge range of 
organisms; the specificity of the system derives from the pattern 
produced, not the detection of a species-specific marker. Regardless 
of organism, the same techniques and reagents are employed, 
eliminating the need for a variety of methods for different 
organisms. The system is currently being developed by Grimont at 
the Pasteur Institute, and has already been applied to typing a wide 
range of phylogenetically diverse organisms, including several 
species for which no satisfactory typing system had been developed 
(Irino et al, 1988; Grimont et al, 1989). DNA probes have yet to be 
employed in the study of the epidemiology of MRSA infection,
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although the availability of suitable probes makes such application 
virtually inevitable.
PATHOGENICITY OF STAPHYLOCOCCUS AUREUS
As has been mentioned, Staph, aureus possesses a very 
wide armamentarium of pathogenic mechanisms. These virulence 
factors can be subdivided according to their location as either cell 
wall associated or extracellular.
Cell wall associated factors
The cell-wall peptidoglycan has a number of important 
biological properties: it can stimulate endogenous pyrogen 
production by human monocytes, has endotoxin-like activity and can 
activate complement. In addition it can attract polymorphonuclear 
leucocytes and is able, in association with teichoic acids, to elicit the 
production of antibodies (Kaplan and Tenenbaum, 1982).
Protein A is a cell-wall protein with molecular weight of 
42,000, which is present in over 90 % of Staph, aureus isolates. 
Protein A can activate complement and is capable of inducing 
immediate and delayed type hypersensitivity. In addition it is 
chemotactic for leucocytes, can activate lymphocytes and 
macrophages and binds the Fc receptor of all human IgG subclasses, 
except IgG3 (Forsgren et al, 1983).
Some strains of Staph, aureus seem capable of elaborating a 
polysaccharide capsule. The incidence of capsule production has
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been variously reported in between 0.6 % and 18.4 % of strains, 
depending on the freshness of the clinical isolates examined. It 
seems likely that these figures may well be higher for organisms 
growing in vivo. Capsulated strains are more lethal for mice and 
much less susceptible to phagocytosis. This latter phenomenon is 
thought to be due to interference with the interaction of C3b bound 
to the bacterial cell-wall and the C3b receptor on the cell membrane 
of the phagocytic cell (Wilkinson, 1983).
Extracellular products
Staph, aureus produces and secretes a number of enzymes 
and toxins which have been variously implicated in the 
pathogenicity and invasiveness of the organism. The difficulties in 
elucidating their precise role are compounded by the technical 
problems in purifying these unstable substances. As a result there is 
still much controversy about their individuality, specificity and 
ultimately their in vivo activity. It is likely that the advent of 
modern techniques of molecular biology will permit the preparation 
of more highly purified material, both by means of cloning and 
controlled expression of toxin genes, and by improved techniques 
for molecular separation.
Enzymes
Table III lists many of the enzymes known to be secreted by 
Staph, aureus. The majority of these enzymes degrade 
macromolecular substrates including proteins, nucleic acids, lipids
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and polysaccharides to provide low molecular weight nutrients for 
bacterial growth. Although there is a high correlation between 
pathogenicity of Staph, aureus and production of extracellular 
enzymes, there is no evidence to indicate that the ability of 
staphylococci to cause disease is related to any single substance 
(Arvidson, 1983).
Table III. Extracellular enzymes of Staphylococcus aureus
Coagulase 
Nuclease 
Lipase 
Catalase 
Phosphatase 
Endopeptidase 
Hyaluronate lyase 
Lysophosphatidase 
Staphylokinase 
Proteinases
Phosphatidylcholine: cholesterol o-acyl-transferase 
Endopeptidase 
Ehdo-jS-N-acetylglucosaminidase 
N-acetylmuramyl-L-alanine amidase
Those enzymes which may be most closely associated with 
pathogenicity include coagulase, hyaluronidase, nuclease, lipase and 
catalase. Coagulase, which causes plasma to clot by activation of 
the final steps of the coagulation cascade, is thought to interfere with 
opsonophagocytosis. Hyaluronidase may facilitate local tissue 
invasion by digestion of acid mucopolysaccharides in the acellular 
connective tissue matrix. Staphylococcal nuclease, which possesses 
both exo- and endonuclease activity, is involved in the degradation 
of nucleic acids. Lipase activity may play some role in the 
formation of local suppurative lesions, and the dissemination of
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infections (Noble and White, 1983; Arvidson, 1983). Catalase, 
which catalyses the breakdown of hydrogen peroxide into water and 
oxygen, is thought to play a role in the neutralisation of toxic oxygen 
radicals synthesised by phagocytic cells (Mandell, 1975).
Toxins
Staph, aureus produces a variety of extracellular products 
which are defined as toxins by virtue of their ability to affect host 
cell function and/or morphology; although some of them mediate 
their toxic effects by virtue of their enzymatic activity, and might 
therefore be considered as enzymes. The diseases known to be 
mediated by specific staphylococcal toxins, which include 
staphylococcal enterocolitis, staphylococcal food poisoning, 
exfoliative skin disorders and the toxic shock syndrome, have been 
reviewed by Bass (Bass, 1982). The major Staph, aureus toxins are 
listed in Table IV.
Table IV. Toxins of Staphylococcus aureus.
Alpha haemolysin 
Beta haemolysin 
Gamma Haemolysin 
Delta Haemolysin 
Epidermolytic toxins (ETA and ETB)
Enterotoxins (A-E)
Panton-Valentine leucocidin 
Toxic shock syndrome toxin (TSST-1)
The epidermolytic toxins are involved in the pathogenesis of 
the staphylococcal scalded skin syndrome and related conditions 
(Melish and Glasgow, 1970). There are 2 types, A  and B, of
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molecular weights 26,500 and 26,000 respectively. Epidermolytic 
toxin A (ETA) is heat stable and chromosomally encoded, whilst 
epidermolytic toxin B (ETB) is heat labile and plasmid encoded. 
Although initially associated with phage group II isolates, 
subsequent work has demonstrated production of ETA and ETB by a 
wide range of phage types (Arbuthnott, 1983). The precise 
molecular mode of action of the toxin remains undefined, although 
phospholipase activity has been demonstrated in electrofocused 
toxin (Wiley and Rogolsky, 1985).
Five membrane damaging toxins have been described in 
Staph, aureus. These are a-toxin, (3-toxin, y-toxin, 6 -toxin and 
leucocidin. a - ,  (3-, y -  and 6 -  toxins are frequently referred to as 
haemolysins, as their haemolytic activity is the most common 
method used for their detection in vitro, a -tox in  is a protein of 
molecular weight 28,000-39,000. It is a surface active agent, which 
is capable of lysing a variety of cells by interaction with cell-surface 
receptors (Molby, 1983; Thelestam, 1983; Fackrell et al, 1985). p -  
toxin is a Mg2+-dependent sphingomyelinase C of molecular weight 
26,000-38,000, which also possesses activity against a wide range of 
cell types. The observed variation of susceptibility to lysis by p -  
toxin of erythrocytes from different species reflects the variable 
proportions of sphingomyelin in their cell membranes (Molby, 1983; 
Thelestam, 1983). The mode of action of y-toxin is poorly defined, 
although it may be a phospholipase-like activity. It is a protein of 
molecular weight 29,000-46,000, and demonstrates wide activity
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against a range of erythrocytes, y-toxin is inactivated by acid 
polysaccharides, including agar, and this fact must be borne in mind 
when attempting to demonstrate toxin activity in vitro (Molby, 1983; 
Thelestam, 1983). 6 -toxin is a multimeric protein of molecular 
weight 200,000. It is a surface active agent which is capable of 
damaging a large variety of cell types by means of poorly defined 
mechanisms, which may involve the formation of trans-membrane 
pores (Freer and Birkbeck, 1982; Molby, 1983; Thelestam, 1983). 
Leucocidin is exclusively active against leucocytes, and consists of 2 
protein components F and S of molecular weights 32,000 and 31,000 
respectively. Membrane damage is inflicted by the activation of an 
endogenous membrane associated phospholipase A2  activity 
(Molby, 1983; Thelestam, 1983). The biological effects of these 
toxins has been reviewed in detail by Wadstrom (1983).
The enterotoxins A, B C1.3 , D and E are a series of low 
molecular weight proteins (25,000-30,000) of similar activity and 
composition, but which may be identified as separate proteins on the 
basis of antigenic differences. In addition to their well recognised 
role in the pathogenesis of staphylococcal food poisoning, 
enterotoxins have been implicated in other manifestations of 
staphylococcal disease, including some cases of toxic shock 
syndrome (Crass and Bergdoll, 1986). Although their precise mode 
of action is ill defined, both local and central mechanisms have been 
proposed. They are mitogenic, and following intragastric
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administration are associated with an influx of lymphocytes into the 
gastrointestinal tract (Bergdoll, 1983; Bergdoll, 1985).
Originally designated as enterotoxin F, Toxic Shock 
Syndrome Toxin 1 (TSST-1), is now recognised as the toxin 
implicated predominantly in the pathogenesis of toxic shock 
syndrome. TSST-1 is a protein of molecular weight 24,000, and 
shows many similarities to the staphylococcal enterotoxins, 
including the presence of a so-called "cystine-loop" structure 
(Bergdoll et al, 1985). TSST-1 has been shown to stimulate 
production of interleukin 1 and tumour necrosis factor. Production 
of TSST-1 by toxigenic strains is greatly suppressed by excess 
Mg2+ ions, and the ability of certain vaginal tampon fibres to act as 
ion exchangers for Mg2+ ions may explain the association of toxic 
shock syndrome with the use of tampons (Kass and Parsonnet, 
1987).
PATHOGENICITY OF MRSA
The pathogenic potential of MRSA with respect to their 
methicillin-sensitive counterparts has been the subject of much 
controversy and speculation amongst all those concerned with the 
control of hospital infection. Lacey and Chopra (1975) were able to 
demonstrate that the acquisition of antibiotic resistance determinants 
in Staph, aureus was associated with a decrease in virulence for 
chick embryos. However, Cutler (1979) showed that guinea-pig 
virulence decreased progressively with the loss of resistance
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determinants. In the clinical setting there can be little doubt that in a 
number of places, including parts of Eastern Australia and the USA, 
and certain Dublin hospitals, MRSA have indeed been responsible 
for serious epidemic outbreaks of nosocomial infection (Pavillard et 
al, 1982; Locksley et al, 1982; Cafferkey et al, 1983; Bacon et al, 
1987; Preheim et al, 1987; Cafferkey et al, 1988; Marples, 1988). In 
the South-East of England, particularly in the Thames NHS regions, 
the spread of so-called epidemic MRSA (EMRSA), and the 
elaborate infection control measures undertaken in attempts to curb 
its spread, have been documented extensively (Cookson et al, 1986; 
Dacre et al, 1986; Marples et al, 1986; Duckworth et al, 1988; 
Marples and Cooke, 1988). Conversely, others have suggested that 
the MRSA problem has been exaggerated, and have been 
correspondingly critical of some of the more elaborate infection 
control procedures which have been undertaken in attempts to 
eradicate these organisms (Lacey et al, 1986; Lacey, 1987).
Some attempts have been made to examine the 
pathogenicity of MRSA in an objective fashion. The production of 
various pathogenicity determinants has been investigated including 
protein A and coagulase (Lacey et al, 1986; Roberts and Gaston, 
1987; Jordens et al, 1989), lipase (Cookson et al, 1986), haemolysin 
(Humphreys et al, 1989; Jordens et al, 1989) and enterotoxin 
(Duckworth and Oppenheim, 1986; Humphreys et al, 1989; Jordens 
et al, 1989). Compared to methicillin-sensitive strains some 
differences have been described such as the low level of protein A
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production in EMRSA reported by Roberts and Gaston (1987). 
However, it would seem reasonable to say that on the available 
evidence, MRSA are probably no more or no less pathogenic than 
their methicillin-sensitive counterparts. Indeed French et al (1990) 
have shown in a comparison of Hong Kong strains that MRSA have 
similar lethality to MSSA, in a mouse model and in vivo, and are 
isolated in similar proportions from deep and superficial clinical 
sites.
These results accord with clinical experience in GRI, where 
excess morbidity and mortality due to MRSA have not been seen. 
The number and severity of infections caused by MRSA correspond 
to the proportion of Staph, aureus isolates in the hospital which 
these strains represent (D R Baird, personal communication). 
Global variations in clinical experience of these organisms probably 
reflect a variety of factors, including differences in patient 
populations studied, the heterogeneous nature of geographically 
distinct isolates of MRSA themselves, and variations in antibiotic 
usage and other selection pressures (French et al, 1990).
Regardless of their pathogenicity when compared to other 
Staph, aureus, it is clear that MRSA are responsible for significant 
infections and that the antibiotics available for treatment are 
significantly curtailed (Musher and Verner, 1985; Waldvogel, 1986). 
Vancomycin remains the mainstay of therapy and, in addition to the 
inevitable anxiety that results from dependence on a single agent, it 
is both inconvenient to administer (Waldvogel, 1986) and potentially
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nephro- and ototoxic (Kucers and Bennett, 1989). These factors 
together with the undoubted potential of all staphylococci to 
colonise and to spread in the hospital environment, are sufficient 
reason to alert hospitals to the continued need for surveillance and 
control of the spread of MRSA (French et al, 1990).
The goal of total eradication is probably unrealistic. They 
are uniquely adapted to the hospital environment consequent upon 
the selective pressures of widespread use, and abuse, of broad- 
spectrum antibiotics. Against such a background, attempts at 
complete control can be extremely costly in terms of time, 
manpower and resources (Pearman et al, 1985). It may be that 
infection control strategies will have to rely increasingly on 
monitoring the spread of MRSA, and intervening only when 
significant levels of nosocomial infection become apparent, or when 
particularly vulnerable patient groups are threatened (Lacey, 1987).
56
CHAPTER 2
Materials and Methods
57
BACTERIAL STRAINS
Methicillin-sensitive Staphylococcus aureus (MSSA)
A total of 163 isolates of MSSA was studied comprising : 
from GRI patients 50 consecutive blood culture isolates collected 
during the period January 1985 to May 1986 (BC) and 63 isolates 
from other routine diagnostic specimens collected between October
1985 and April 1986 (RD). In addition 50 strains cultured from the 
noses of patients attending a general practitioner's surgery (Balfron 
Health Centre, Balfron) were collected between April 1986 and July
1986 (GP). Multiple isolates from the same patient were excluded.
Methicillin-resistant Staphylococcus aureus (MRSA)
A total of 101 isolates of MRSA from GRI patients were 
studied. These isolates comprised an initial collection of 53 isolates 
collected between February 1985 and April 1986 (MRSA(l)), and a 
second collection of 48 isolates from the period May 1986 to July
1987 (MRSA(2)). Approximately half of the isolates were obtained 
from the Regional Burns Unit based at GRI; the remainder were 
isolated from a wide variety of units in the hospital. Multiple 
isolates from the same patient were again excluded. In addition 3 
isolates of epidemic MRSA (EMRSA) from London, two from St. 
Bartholomew's hospital and one from St. Thomas's hospital were 
also examined.
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ISOLATION AND IDENTIFICATION OF ORGANISMS
Organisms from episodes of bacteraemia and septicaemia 
were isolated using the radiometric Bactec system (Becton- 
Dickinson, Cowley) in which the detection of 14C0 2  released from 
a 1 4C-labelled carbon source in the liquid culture medium indicates 
bacterial growth. Subsequent to their isolation, the organisms were 
stored in Robertsons cooked meat broth.
Non-blood culture specimens were collected on standard 
charcoal swabs (Medical Wire and Equipment Company, Corsham) 
and cultured on Columbia Blood Agar (5 % defibrinated horse blood 
in Columbia Agar) and incubated at 37°C for 18 hours in air 
supplemented with 5 % CO2 . Organisms were identified as 
Staphylococcus aureus by their colony morphology and positive 
results in the coagulase test and Staphaurex latex agglutination test 
(Wellcome, Dartford) (Duguid, 1989).
ANTIBIOTIC SUSCEPTIBILITY TESTING
Sensitivity to methicillin (10 jag), rifampicin (2 jag), 
streptomycin (10 jag), kanamycin (30 jag), gentamicin (10 jag), 
vancomycin (30 jag), trimethoprim (2.5 jag), mupirocin (5 jag), 
penicillin G (2 jag), erythromycin (5 jag), clindamycin (2 jag), fucidin 
( 1 0  jag), tetracycline ( 1 0  jag), chloramphenicol ( 1 0  jag) and 
teicoplanin (30 jag) was determined by disc-diffusion tests. Five 
colonies from an overnight culture of the test organism were 
suspended in a 2 ml volume of Isosensitest broth (Oxoid,
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Basingstoke); a l/300th ml loopful of this suspension was spread out 
onto an Isosensitest agar plate and antibiotic discs applied. 
Sensitivity-test plates were incubated for 18 hours at 37°C in air 
(30°C in the case of methicillin). The radii of the resultant inhibition 
zones were compared with critical radii (Rc) previously determined 
for a fully sensitive strain of Staph, aureus (GRI 22686). The 
critical radii were calculated from Rc = (x-3cr), where x was the 
mean radius obtained from twelve determinations and a  was the 
standard deviation. If an antibiotic produced an inhibition zone 
which was less than Rc, the isolate was deemed to be resistant to 
that agent (Platt et al, 1986a).
PHAGE TYPING
Phage typing of 45 MRSA(l) isolates was performed as 
previously described (Coia et al, 1988) by the staphylococcal 
reference laboratory of the Central Public Health Laboratory 
(CPHL) Colindale, London. The isolates were typed with the 
standard international set of phages, and with the additional set used 
to type MRSA (616, 617, 618, 620, 622, 623, 625, 626, 629 and 
630). In addition 34 of the isolates were typed with phages 8 8 A, 90, 
83C and 932.
BIOTYPING
Biotyping of 45 MRSA(1) isolates was performed as 
described previously (Coia et al, 1990) by Dr Dugald Baird. Simple
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biotyping was based on three properties:- hydrolysis of tween 80, 
pigmentation on tween 80 agar and urease production.
Tween 80 (1 % v/v) was incorporated in nutrient agar 
(Oxoid, Basingstoke), and the test organism spread over an area 
approximately 1 cm diameter. Plates were incubated at 37°C for 2-3 
days. A  positive test was denoted by the appearance of a halo of 
fatty acids around the inoculum. This medium enhanced 
pigmentation of Staph, aureus, and isolates were described as gold, 
buff or cream.
Urease production was tested in 1 ml volumes of brain-heart 
infusion broth (Oxoid, Basingstoke) containing 2 % urea and 
0.0012 % phenol red as indicator. A  heavy inoculum was used. 
After 18-48 hours incubation at 37°C, a positive test was indicated 
by a deep red colour of the medium. Urease non-producers turned 
the medium yellow.
PREPARATION OF IMMUNOBLOTS OF EXPORTED
PROTEINS
Immunoblotting of exported proteins from 45 MRSA(1) 
isolates was performed by Dr. F. Thomson-Carter in the University 
Department of Bacteriology, Aberdeen, as previously described 
(Coia et al, 1990). Isolates were inoculated on to nutrient agar 
plates and incubated for 24 hours at 37°C. Sufficient growth was 
harvested from these plates to provide approximately 2  fig  bacterial 
dry weight/ml; this was inoculated into 150 ml of nutrient broth and
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incubated for 18 hours at 37°C in an orbital incubator. After 
centrifugation at 10000 x g for 15 minutes at 4°C, the upper 10 ml of 
supernatant containing the exported proteins was retained for 
immunoblot analysis.
SDS polyacrylamide gel electrophoresis (SDS-PAGE) was 
used to separate the proteins by a modification of the technique of 
Laemmli (1970). Samples were prepared by mixing two parts of the 
supernatant with one part 0.5 M Tris-HCl, pH 6 . 8  containing SDS 
6  % w/v, glycerol 30 % w/v, 2-mercaptoethanol 15 % w/v, and 
bromophenol blue 0.001 % and boiling for 5 minutes. Samples 
containing 40 fjug protein were loaded into wells in a 3.6 % 
acrylamide stacking gel over a 10 % acrylamide separating gel. The 
proteins were separated by electrophoresis in a discontinuous buffer 
system at 30 mA constant current for 4-5 hours.
Proteins from the gels were blotted on to nitrocellulose 
membranes in 25 mM Tris-HCl, 192 mM glycine buffer, pH 8.3, 
containing methanol 20 % v/v (Burnette, 1981). A  current of 
100 mA applied overnight in a Bio-Rad transblot cell was used to 
transfer the proteins. A 30 minute incubation in blocking buffer 
containing newborn calf serum (Gibco-BRL, Paisley) 10 % v/v in 
phosphate-buffered saline, pH 7.4, Triton X-100 0.2 % v/v
(PBS/Triton), served to saturate free protein sites. The nitrocellulose 
membrane was then incubated in test human plasma diluted 1 in 50 
with blocking buffer for 90 minutes. The test human plasma was 
prepared from a pool known to contain antibodies against a range of
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staphylococcal polypeptides (Krikler et al, 1986). The membranes 
were then given three 15 minute washes in PBS/Triton, prior to 
incubation for 45 minutes with horseradish peroxidase-linked sheep 
anti-human IgG serum (Scottish Antibody Production Unit, Carluke) 
diluted 1 in 1000 in blocking buffer. Three more washes in 
PBS/Triton were then performed and the membranes rinsed in PBS 
alone prior to staining with diamino-benzidine tetrahydrochloride 
(BDH, Poole) 0.05 % w/v in 0.1 M Tris-HCl, pH 7.6, containing 
hydrogen peroxide 0 . 0 1  % v/v.
DETERMINATION OF PLASMID PROFILES
Plasmid profiles were determined by a modification of the 
method of Platt and Sommerville (1981) as described by Coia et al 
(1988). About 25 % of the growth from an overnight culture on 
nutrient agar at 37°C was harvested using a dry cotton wool swab 
and suspended in 500 p i of a solution containing 50 mM Tris, 
50 mM NaCl and 5 mM disodium EDTA, pH 8.0 (TES) in 
Eppendorf tubes. The cells were pelleted by centrifugation at 
15000 x g for 30 seconds and the supernatant discarded. The cells 
were resuspended in 400 p i of TES containing 50 mM sucrose 
(TESS) to which 50 p i of a solution of lysostaphin (1 mg/ml in TES, 
Sigma Chemicals, Poole) and 50 p i of a solution of lysozyme (40 
mg/ml in TES, Sigma Chemicals, Poole) were added. After 
incubation for 10 minutes at 37°C, 400 p i of a solution of sodium 
dodecyl sulphate, 10 % w/v (SDS) was added to complete lysis. The 
lysates were centrifuged for 15 minutes at 15000 x g and the bulky
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pellets discarded. One hundred microlitre aliquots of the resulting 
plasmid-bearing supernatants were loaded onto a vertical agarose gel 
(0.7 % w/v in 89 mM Tris, 89 mM borate and 1.25 mM EDTA, 
pH 8.2 (Tris-borate)) and 5 fi1 of tracker dye (0.05 % w/v 
bromophenol blue, 0.1 % w/v SDS, 8  mM sodium acetate in 
25 % w/v sucrose) added to each well. The plasmids were separated 
by electrophoresis for 5 hours at 20 V/cm as described by Platt and 
Sommerville (1981) and Platt et al (1984). The gels were stained for 
30 minutes in ethidium bromide solution (1.6 /jlM  in Tris-borate), the 
plasmid bands visualised by ultra-violet light (360 nm) on a 
transilluminator and photographed using a Polaroid MP4 camera 
(665 film: 40 second exposure, f 5.6). The molecular sizes of the 
plasmids were estimated by comparison with plasmids of known 
size (96, 42, 24 and 4.6 Md isolated from the multiplasmid 
Escherichia coli strain 39R861). The sizes of small plasmids were 
estimated by comparing their mobility with that of a set of low 
molecular weight standard supercoiled plasmids (Supercoiled 
Ladder, Gibco-BRL, Paisley), as described previously by Platt and 
Taggart (1987).
PREPARATION OF PURIFIED PLASMID DNA
Purified staphylococcal plasmid DNA was prepared by a 
modification of the method of Platt et al (1986b), as described by 
Coia et al (1988). Cultures incubated overnight in 10 ml of brain 
heart infusion broth (BHI) were centrifuged at 2000 x g  for 5 
minutes. The cell pellet was resuspended in 1 ml TES buffer, and
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each sample then divided into two Eppendorf tubes. Following 
centrifugation at 15000 x g for 30 seconds, the cell pellets were 
resuspended in 200 p i of TESS to which 50 pi of lysozyme (40 
mg/ml) and 50 p i of lysostaphin (1 mg/ml) were added. Four 
hundred microlitres of a freshly prepared alkaline SDS solution (1 % 
SDS, 0.2 M NaOH) was added to each tube, followed by gentle 
inversion to complete cell lysis. After incubation for 5 minutes at 
4°C, 300 p i of 3 M sodium acetate solution was added and the tubes 
gently inverted until a white precipitate was visible. After thorough 
vortex mixing the samples were again incubated for 5 minutes at 
4°C, prior to centrifugation at 15000 x g for 2 minutes. 0.5 ml of 
(1 :1 ) phenol/chloroform mixture was added to the resulting 
supernatants prior to vortex mixing and further centrifugation at 
15000 x g for 2 minutes. The upper aqueous layer was retained after 
centrifugation and 0.5 ml of propan-2-ol added. The samples were 
allowed to stand for at least 5 minutes at room temperature.
After further centrifugation for 2 minutes at 15000 x g the 
pellet was resuspended in 100 p i of a solution containing 10 mM 
Tris and 1 mM EDTA, pH 8.0 (TE). After 5 minutes the duplicate 
tubes were pooled and 100 p i of 7.5 M ammonium acetate solution 
added. 0 . 6  ml of ice-cold 1 0 0  % ethanol was then added and the 
samples kept at -20°C overnight.
After centrifugation for 2 minutes at 15000 x g the resulting 
pellets were resuspended in 160 p i TE buffer and 18 p i of 
ribonuclease ( 1  pg/ml) added. After incubation for 30 minutes at
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37°C, 20 ill of 2.5 M sodium chloride solution was added. Once 
again 0.5 ml of phenol/chloroform mixture was added and the upper 
aqueous layer separated by centrifugation and retained as before.
0.5 ml of propan-2 -ol was added and the tubes allowed to 
stand a further 5 minutes at room temperature. After centrifugation 
for 2 minutes at 15000 x g the pellets were resuspended in 100 fil TE 
buffer and 100 fil 7.5 M ammonium acetate added. After the 
addition of 0 . 6  ml of ice-cold 1 0 0  % ethanol the tubes were again 
kept at -20°C overnight. Finally the samples were centrifuged for 2 
minutes at 15000 x g and the pellets of purified plasmid DNA 
resuspended in 60 fil of TE buffer.
RESTRICTION ENDONUCLEASE DIGESTION
The purified plasmid DNA was digested with restriction 
endonuclease enzymes according to the strategy previously 
described by Platt et al (1986b); the enzymes used were Pstl, HaeIII 
and Alul (Gibco-BRL, Paisley). The resultant fragments were 
separated by electrophoresis to generate restriction enzyme 
fragmentation patterns (REFP). In addition, the enzymes Avail, 
Hindlll, Smal, EcoRl, Bspl286  and A M  (Gibco-BRL, Paisley) were 
employed in attempts to cleave low molecular weight plasmids 
present in some of the isolates.
To each reaction tube was added 5 /xl of the appropriate 
reaction buffer for each enzyme, as supplied by the manufacturer 
(Gibco-BRL, Paisley). Two microlitres of the enzyme (20 units)
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and 15-20 fil of purified plasmid DNA solution was then added and 
the volume made up to a total of 50 p i with sterile distilled water. 
The reaction mixtures were then incubated at 37°C (30°C for Smal) 
for 4 hours to facilitate digestion. Molecular weight standards were 
generated by the substitution of bacteriophage lambda DNA (Gibco- 
BRL, Paisley) in place of sample DNA in the reaction mixture, and 
digestion with the enzyme Pstl. After incubation 5 p 1 of tracker dye 
was added to each tube and the mixtures loaded into the wells of a 
horizontal agarose gel (0.8 % in Tris-borate buffer containing 
0.3 jug/ml ethidium bromide). The restriction fragments were 
separated by electrophoresis for 18 hours at 2 V/cm (18 mA constant 
current), visualised on the ultra-violet transilluminator, and then 
photographed as previously described for plasmid profile gels. The 
sizes of the DNA fragments generated by restriction endonuclease 
digestion were estimated from a standard curve produced by fitting a 
robust modified hyperbola to the observed mobilities of the 
fragments of known molecular weight of bacteriophage lambda 
DNA digested by the enzyme Pstl (Plikaytis et al, 1986).
ENTEROTOXIN PRODUCTION
Production of Staphylococcus aureus enterotoxins A, B, C, 
and D by 152 MSSA and 49 MRSA(l) isolates was determined by 
reverse passive latex agglutination (RPLA), using commercial SET- 
RPLA kit tests (Oxoid, Basingstoke), according to the manufacturers 
instructions (Humphreys et al, 1989). Culture supernatants of test 
organisms were prepared as described previously for
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immunoblotting. Twenty-five microlitres of phosphate buffered 
saline containing 0.5 % w/v bovine serum albumin was dispensed 
into each well of 5 rows of a V-bottomed microtitre plate. Twenty- 
five microlitres of the test culture supernatant was then dispensed 
into the first well of each of the five rows and doubly diluted. The 
dilutions were not extended into the last well of each row. To each 
well of the first row was added 25 yX of latex sensitised with rabbit 
anti-staphylococcal enterotoxin A IgG antibodies. In an analogous 
fashion 25 yX of anti-enterotoxin B sensitised latex was added to 
each well of row 2, 25 yX of anti-enterotoxin C sensitised latex to 
each well of row 3, 25 yX of anti-enterotoxin D sensitised latex to 
each well of row 4, and 25 yX of a control latex suspension coated 
with non-immune rabbit globulins to each well of row 5. The 
contents were mixed thoroughly by micromixer, covered, and left 
undisturbed on a vibration-free surface at room temperature for 2 0 - 
24 hours. Each of the test wells (rows 1-4) was then examined for 
agglutination which indicated the presence of the respective 
enterotoxin (A, B, C or D). In this manner the number and type of 
enterotoxins produced by each isolate could be detected. Non­
agglutination in row 5 and in the last well of rows 1-5 served to 
exclude spurious non-specific agglutination and auto-agglutination, 
respectively.
DETECTION OF HAEMOLYSINS
Staphylococcus aureus a - ,  p -, y -  and 6 -haemolysin 
production by 152 MSSA and 49 MRSA(l) isolates was detected by
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a modification of methods described elsewhere, (Chao et al, 1978; 
Humphreys et al, 1988). Rabbit anti-a antiserum and 6 -haemolysin 
were supplied by Dr. T. H. Birkbeck, Department of Microbiology, 
University of Glasgow.
Five colonies of each organism under investigation were 
inoculated into 1 ml volumes of BHI broth and incubated for 18 
hours at 37°C in air. The organisms to be tested for a - ,  p~, y -  and 
5-haemolysins were then inoculated in batches of 2 0 , using a multi­
point apparatus, onto 3 nutrient agar plates. Organisms to be tested 
for y-haemolysin were inoculated in an analogous fashion onto a 
nutrient agarose plate. The plates were then incubated for 18 hours 
at 37°C in air.
a-haemolysin
Production of a-haem olysin was detected as follows. The 
nutrient agar plates were overlaid with 5 ml of 5 % v/v rabbit blood 
agar. After the agar had set, 2 mm diameter wells were cut in the 
agar in the spaces between the test strains. Into these wells were 
dispensed 5 fil aliquots of rabbit anti-a-haemolysin antiserum. 
After incubation for 24 hours in air at 37°C, the plates were 
examined for haemolysis, with specific inhibition of a-haem olysin 
activity around the wells containing antiserum.
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3 -haemolysin
The following procedure was used to detect (3-haemolysin 
activity. The nutrient agar plates were overlaid with 5 ml of 5 % v/v 
sheep blood agar. After the agar had set, 2 mm diameter wells were 
cut in the agar in the spaces between the test strains. Into these 
wells were dispensed 5 /jl1 aliquots of 6 -haemolysin. After 
incubation for 24 hours in air at 37°C, the plates were examined for 
haemolysis due to p-haemolysin, which could be recognised by 
enhancement around the wells containing 6 -haemolysin.
Y-haemolysin
Production of Y“ haem°lysin was determined in an 
analogous fashion to that used for a-haemolysin. The nutrient 
agarose plates were overlaid with 5 ml of 5 % v/v rabbit blood 
agarose. After the agar had set, 2 mm diameter wells were cut in the 
agar in the spaces between the test strains. Into these wells were 
dispensed 5^1 aliquots of rabbit anti-a-haemolysin antiserum. 
After incubation for 24 hours in air at 37°C, the plates were 
examined for haemolysis. Spurious a-haem olysin activity was 
inhibited by the specific antiserum.
5-haemolysin
Production of 6 -haemolysin was determined as follows. 
The nutrient agar plates were overlaid with 5 ml of 5 % v/v cod 
blood agar. The plates were then incubated for 4-8 hours at 4°C and 
observed for haemolysis.
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STATISTICAL ANALYSIS
The overall similarity of any two isolates represented by 
either immunoblot profile or REFP was determined by calculation of 
the similarity co-efficient of Dice (Sd) (Dice, 1945), as follows
Average similarity = Number of matching bands x 2
Total number of bands in both isolates.
The distribution of immunoblot types within each REFP 
group, the distribution of biotypes within each of the major 
REFP/Immunoblot groups and the distribution of enterotoxins and 
haemolysins amongst the various collections of organisms was 
compared by means of the Chi-squared test (Siegel, 1956).
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CHAPTER 3
Results
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ANTIBIOTIC SUSCEPTIBILITY TESTING
Antibiograms
The complete antibiograms of all the isolates are listed in 
Appendix 1, together with details of the collection to which they 
belong. Table V shows the numbers and percentage of isolates in 
each of the collections resistant to each of the antibiotics tested. 
Penicillin resistance, as would be expected, was by far the most 
common resistance seen in the MSSA isolates.
Table V. Numbers of isolates in each collection resistant to individual
antibiotics
Number(%) of isolates resistant 
to given antibiotic
Antibiotic BC GP RD MRSA(1 ) MRSA(2)
(n=50) (n=50) (n=63) (n=53) (n=48)
Rifampicin 0 (0 ) 0 (0 ) 0 (0 ) 0 (0 ) 0 (0 )
Streptomycin 1 (2 ) 2(4) 2(3) 25 (47) 28 (58)
Kanamycin 1 (2 ) 1 (2 ) 3(5) 25 (47) 29 (60)
Gentamicin 0 (0 ) 1 (2 ) 2(3) 25 (47) 29 (60)
Vancomycin 0 (0 ) 0 (0 ) 0 (0 ) 0 (0 ) 0 (0 )
Trimethoprim 0 (0 ) 1 (2 ) 1 (2 ) 2(4) 0 (0 )
Mupirocin 0 (0 ) 0 (0 ) 0 (0 ) 1 (2 ) 1 (2 )
Penicillin 46 (92) 37 (74) 51 (81) 53 (100) 48 (100)
Methicillin 0 (0 ) 0 (0 ) 0 (0 ) 53 (100) 48 (100)
Erythromycin 3(6) 3(6) 8(13) 52 (98) 48(100)
Clindamycin 0 (0 ) 0 (0 ) 0 (0 ) 0 (0 ) 0 (0 )
Fucidin 4(8) 0 (0 ) 7(11) 2(4) 0 (0 )
Tetracycline 4(8) 9(18) 17 (27) 51 (96) 47 (98)
Chloramphenicol 0 (0 ) 0 (0 ) 0 (0 ) 1 (2 ) 1 (2 )
Teicoplanin 0 (0 ) 0 (0 ) 0 (0 ) 0 (0 ) 0 (0 )
Table VI shows the percentage of isolates in each group 
resistant to none, one, two or three or more of the antibiotics tested. 
All the MRSA were resistant to three or more antibiotics (Figure 2).
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Table VI. Distribution of resistance determinants in isolates from
different sources
Resistance
determinants
Percentage of isolates resistant to 
the given number of antibiotics
BC GP RD MRSA(l) MRSA(2)
0 6 32 1 1 0 0
1 78 54 53 0 0
2 1 0 1 0 24 0 0
> 3 6 4 1 2 1 0 0 1 0 0
Aminoglycoside-resistance
Almost equal numbers of aminoglycoside-sensitive and 
aminoglycoside-resistant organisms (on the basis of sensitivity or 
resistance to gentamicin, streptomycin and kanamycin) were found 
in each of the two MRSA collections. Aminoglycoside-resistant 
MRSA (MRSA(R)) were predominantly, though by no means 
exclusively, isolated from patients in the Regional Burns Unit, 
whereas aminoglycoside-sensitive MRSA (MRSA(S)) were found 
mainly in the dermatology unit. Two antibiograms accounted for 
> 90 % of the total combined MRSA isolates (Table VII).
Mupirocin-resistance
One of the MRSA was found to be resistant to the topical 
antibiotic mupirocin (Baird and Coia, 1987). The isolation of this 
organism predated the widespread introduction of mupirocin into 
clinical use.
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Table VII. Distribution of MRSA antibiograms
Number (%) of isolates with the 
given antibiogram
Resistance
Markers
MRSA(l) 
(n = 53)
MRSA(2) 
(n = 48)
P Met Tet Ery 24 (45) 18 (38)
P Met Tet Ery 
Sm Km Cn 25 (47) 28 (58)
Other 4(8) 2(4)
P = Penicillin, Met = Methicillin, Tet = Tetracycline, Ery = Erythromycin, 
Sm = Streptomycin, Km = Kanamycin, Cn = Gentamicin.
BIOTYPING
Biotyping divided the isolates into 4 groups (A-D) as shown 
in Table VIII. There was a positive correlation between urease 
production and gentamicin resistance in our strains. Tween 
hydrolysis was of particular value in separating gentamicin-resistant 
strains into two groups arbitrarily designated B and D, as they had 
similar antibiograms. Although the B strains were more highly 
resistant to gentamicin they were difficult to distinguish on routine 
sensitivity testing. Their epidemiology however was quite different; 
the B strains were confined essentially to the burns unit, whereas the 
D strains, though common in that unit, were encountered frequently 
elsewhere.
The strains designated A were first isolated from the 
dermatology unit, and were at the time of the study, also present in
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an orthopaedic ward and two associated hospitals. Organisms 
biotyped as C represented a small, less well defined group, mostly 
appearing sporadically, and with little tendency to spread.
Table VIII. Biotypes of MRSA
Biotype
A B C D
Tween 80 Negative Negative Positive Positive
Urea Negative Positive Negative Positive
Pigmentation Cream Buff Variable Gold
Aminoglycoside Sensitive Resistant Sensitive Resistant
IMMUNOBLOTTING
Reproducible banding patterns were obtained by the 
preparation of immunoblots of culture supernatants. Typical results 
are shown in Figure 3. Each track contained between 33 and 43 
bands, with an average of 39. The banding patterns could be divided 
into two major groups (BLOT1 and BLOT2). Dice analysis of the 
BLOT1 group of 19 isolates showed an average similarity of 94% 
(range 85 to 98%). The BLOT2 group comprised 24 isolates with an 
average similarity of 98% (range 94 to 100%). Comparisons 
between these groups demonstrated a lower inter-group average 
similarity of 61% (range 57 to 83%). A third minor group (BLOT3) 
comprised two isolates with an average similarity of 82%. Thus 
MRSA could be divided into groups on the basis of inter-group 
dissimilarity and intra-group similarity of their immunoblot profiles.
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17 18 25 157 30469  52 80  81 82  149 153
26 298 292 283 273 51 291 288 274
83 295 289 277 159 294 290 278 272
Figure 3. Typical immunoblots of MRSA culture supernates 
(numbers refer to isolates- add suffix 86).
PLASMID PROFILES
Plasmid-bearing isolates
Of the 163 MSS A strains, plasmids were detected in 42 % 
(21/50) of the BC isolates, 48 % (24/50) of the GP isolates and 41 % 
(26/63) of the RD isolates. The remainder of the BC, GP and RD 
isolates were found to be plasmid-free. In contrast, all of the 101 
MRSA(1) and MRSA(2) isolates harboured plasmids. The number 
of plasmids harboured by each isolate is shown in Appendix 1. The 
minimum and maximum number of plasmids harboured by 
individual MSSA isolates was 0 and 2 respectively, whereas for the 
MRSA these figures were 1 and 4.
Distribution of plasmids
Table IX. Frequency distribution of plasmids in isolates from different
sources
Plasmids 
per isolate
Number(%) of isolates with the given 
number of plasmids
BC
(n=50)
GP
(n=50)
RD
(n=63)
MRSA(1)
(n=53)
MRSA(2)
(n=48)
0 29 (58) 26 (52) 37 (59) 0 (0 ) 0 (0 )
1 19 (38) 22 (44) 22 (35) 6 (1 1 ) 6(13)
2 2(4) 2(4) 4(6) 44 (83) 41 (85)
3 0 (0 ) 0 (0 ) 0 (0 ) 2(4) 1 (2 )
4 0 (0 ) 0 (0 ) 0 (0 ) 1 (2 ) 0 (0 )
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The frequency distribution of plasmids in isolates from the 
different sources is shown in Table IX. The distributions observed 
in the BC, GP and RD collections did not differ significantly 
(p > 0.5). Similarly, the distributions found in the MRSA(l) and 
MRSA(2) groups were not significantly different (p > 0.5) 
(Figure 4). In view of the similarity in these distributions the results 
of the MSSA groups were combined for the purpose of comparison 
with the results of the MRSA collections which were also merged 
due to their similarity (Table X). This demonstrated a clear and 
significant difference in the plasmid distributions between the 
MSSA and MRSA groups (p < 0.001) (Figure 5).
Table X. Frequency distribution of plasmids in combined MSSA and 
MRSA isolates compared
Plasmids 
per isolate
Number(%) of isolates with the given 
number of plasmids
All MSSA 
(n=163)
All MRSA 
(n=1 0 1 )
0 92 (56) 0 (0 )
1 63 (39) 1 2  (1 2 )
2 8(5) 85 (84)
3 0 (0 ) 3(3)
4 0 (0 ) 1 (1 )
Plasmid sizes
The molecular sizes of the plasmids ranged from 
approximately 3 kb to 51 kb, and these could be divided into two
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groups; one of 15 kb to 51 kb, and one of 3 kb to 6  kb. Where an 
isolate was found to harbour a single plasmid, this plasmid was 
invariably of the larger size group: the small-size-group plasmids 
were never found alone. If an isolate harboured more than a single 
plasmid, a representative of each of the size groups was invariably
present. Figures 6  and 7 show some typical MSSA and MRSA
plasmid profiles which demonstrate these features. The thickened 
diffuse central band in each lane is derived from chromosomal 
DNA. Plasmid DNA bands appear as the much thinner and sharper 
bands present above and below the chromosomal band.
RESTRICTION ENZYME FRAGMENTATION PATTERNS 
Number of REFPs
The 172 isolates (71 MSSA and 101 MRSA) which were 
found to harbour plasmids yielded a total of 56 unique restriction 
enzyme fragmentation patterns. The HaeRl REFP of all the
plasmid-bearing isolates are shown in Appendix 1. For all the
isolates, the HaeIII restriction patterns correlated well with those 
obtained by digestion with Pstl and Alul. Typical REFPs are shown 
in Figures 8  and 9.
MRSA isolates
MRSAffl
The MRSA(l) isolates yielded 11 different REFPs 
(Figure 10). Dice analysis of these patterns identified 2 major
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Figure 8. Typical HaeIII restriction patterns of S. aureus. Lanes 1- 
4 and 5-12 are from two different gels; lanes 4 & 5-bacteriophage 
XJPstl fragments as calibration standards from each gel; lane 12- 
bacteriophage X/Haelll fragments as calibration standards; lanes 1-3 
-EMRSA; lanes 6 & 8- MRSA(1)(R); lanes 7 & 9-MRSA(l)(S); 
lanes 10 & 11-MSSA. Arrows indicate small multicopy plasmids 
present in MRSA and MSSA and their larger size with respect to 
those found in EMRSA.
1 2 3 4 5 6 7  8 9  101112131415
Figure 9. Typical HaeIII restriction patterns of MRSA. Lanes 1-4, 
5, 6, 7-9, 10-12, and 13-15 are from different gels. Lanes 1, 5, 7, 10 
& 13-bacteriophage X/Pstl fragments as calibration standards from 
each gel; lanes 2 & 6- single-plasmid MRSA(1)(S); lanes 3, 4 & 14- 
two-plasmid MRSA(l)(ft); lane 15- three-plasmid MRSA(1)(S); 
lanes 8 & 9- two-plasmid MRSA(2)(S); lanes 11 & 12- two-plasmid 
MRSA(2)(R).
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groups FP1 and FP2 which corresponded to the two predominant 
MRSA antibiograms described previously. The FP1 group 
comprised 23 isolates, with a mean similarity of 83 % (range 53 to 
100 %). Ten of the FP1 isolates had identical REFPs (Pattern 1, 
Figure 10), and a further 7 had an REFP which differed from this 
predominant pattern only by the absence of 2 bands (Pattern 2, 
Figure 10). Two three-plasmid-bearing isolates (27986 and 28086) 
yielded a further REFP (Pattern 3, Figure 10), whilst the remainder 
of the FP1 group exhibited a variety of different REFPs with varying 
degrees of relatedness to the predominant FP1 pattern (Patterns 3, 4, 
5, 6  and 11, Figure 10). All of the FP1 isolates were 
aminoglycoside-sensitive.
The FP2 group, which were aminoglycoside-resistant, 
comprised 28 isolates with a mean similarity of 97 % (range 71 to 
100 %). Twenty-six of these isolates had identical REFPs 
(Pattern 7, Figure 10), and a further member of the FP2 group 
(30486) differed from this pattern by the absence of only a single 
band (Pattern 8 , Figure 10). One further FP2 REFP was exhibited 
uniquely by isolate 05286 (Pattern 9, Figure 10).
Two isolates (08686 and 30586) did not group with either 
FP1 or FP2 or with each other (percentage similarity 16%), and were 
arbitrarily designated as FP3 and FP4 (Patterns 6  and 10 
respectively, Figure 10), although they were observed to share 
fragments in common with both the predominant FP1 and FP2 
patterns.
80
MRSA(2>)
The 48 MRSA(2) isolates yielded 11 different REFPs 
(Figure 11), of which 4 were also found in the MRSA(l) collection 
(Patterns 1, 2, 9 and 10, Figure 11). Indeed, these common patterns 
included the predominant FP1 and FP2 patterns, and Dice analysis 
subdivided the MRSA(2) isolates into FP1 and FP2 groups as 
before.
The FP1 group comprised 19 isolates with a mean similarity 
of 87 % (range 42 to 100 %). Eight of the FP1 group yielded the 
predominant MRSA(1) FP1 pattern (Pattern 1, Figure 11), whilst a 
further 9 isolates yielded 5 REFPs which differed from this pattern 
only by the presence or absence of between 1 and 3 bands (Patterns 
2, 3, 4, 5, and 6 , Figure 11). Two further isolates (10687 and 10787) 
yielded 2 less closely related FP1 REFPs (Patterns 7 and 8  
respectively, Figure 11).
The MRSA(2) FP2 group comprised 29 isolates with a mean 
similarity of 90 % (range 55 to 100 %). Twenty-six of these isolates 
yielded an REFP identical to the predominant MRSA(1) FP2 pattern 
(Pattern 9, Figure 11). Two further members of the FP2 group 
(13587 and 14587) differed from this pattern by the absence of a 
single band (Pattern 10, Figure 11), whilst the single remaining FP2 
isolate (13187) differed by two bands (Pattern 11, Figure 11).
The FP1 and FP2 groups of the MRSA(2) collection 
corresponded as before with resistance and sensitivity to
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aminoglycoside antibiotics. Patterns 3-6 and 9-11 in Figure 10 and 
patterns 4-8 and 11 in Figure 11 were unique to the MRSA(l) and 
MRSA(2) collections respectively. No isolates corresponding to 
those designated FP3 and FP4 were found among the MRSA(2)
MSSA isolates
The MSSA isolates were in contrast much more 
heterogeneous, a total of 38 different REFPs having been identified 
amongst 71 plasmid-bearing isolates. However 6  different REFPs 
accounted for more than 40 % of plasmid-bearing MSSA isolates 
(Patterns 5, 6 , 7, 8 , 9 and 10, Figure 12). Dice analysis did not 
identify clear sub-groupings, although related REFPs were apparent 
among the patterns observed. Neither of the predominant MRSA 
REFP groups (FP1 and FP2) were similar to the MSSA REFPs 
(Figure 12). Therefore some identical REFPs, and hence plasmids, 
could be found in both community and hospital MSSA (Figure 12) 
but they were not present in MRSA.
Common features
Although common restriction patterns did not occur 
between MRSA and MSSA isolates, certain features of the REFPs 
were found in digests from both the MRSA and MSSA strains. A 
fragment of 2.7 kb after digestion with HaeIII was present in all the 
REFPs from the MRSA isolates and in the patterns from more than 
70% of the MSSA isolates (Figure 13).
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Figure 13. Typical HaeIII restriction patterns of MRSA. Lane 1- 
bacteriophage 'k/Haelll calibration standards; lane 10-bacteriophage 
'k/Pstl calibration standards; lanes 2 & 3 and lanes 4 & 5- 
MRSA(IYR) and MRSA(2)(R) respectively; lanes 6 & 7 and lanes 8 
& 9-MRSA(l)(S) and MRSA(2)(S) respectively. Open arrow 
indicates 2.7 kb Hae III restriction digest fragment present in all 
MRSA, and > 70 % of MSSA, REFPs. Closed arrow indicates small 
multicopy plasmids as found in MRSA and MSSA isolates 
harbouring more than one plasmid.
Small plasmids
Of particular interest were the small, multicopy plasmids 
present in those MRSA and MSSA isolates which harboured two or 
more plasmids. The relatively narrow size range of these plasmids 
revealed by plasmid profile gels has been mentioned already. These 
plasmids were not cleaved following digestion with any of the 
restriction enzymes Pstl, Hae III, Avail, Hindlll, Smal, EcoRI or 
Bspl2S6 , and appeared in the REFPs as a single bright band 
(Figures 8  and 13). However, digestion with the enzyme Alul of a 
variant of isolate 18586, which had spontaneously lost the larger of 
its two plasmids and hence contained only this small plasmid, 
produced five fragments (Figures 14a and 14b). The total molecular 
size of these fragments (2 . 6  kb) agreed well with the estimated size 
of the small plasmid determined from plasmid profile gels. The 
small plasmids in the other MRSA and MSSA isolates were 
similarly cleaved by Alul. In all cases the same 5 fragments could 
be identified in the resulting REFPs, regardless of source. The 
observed differences between patterns 1 and 2, between 3 and 4, 
between 5 and 6 , and between 7 and 8  in Figure 12 reflect the 
presence or absence of this plasmid.
Size heterogeneity
When the molecular weights of the fragments obtained by 
digestion are related to the plasmid profiles, it appears that the 
aminoglycoside-resistant MRSA isolates carried a highly conserved 
plasmid of around 18.3 kb, with a small number of molecular
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1 2  3 4 5 6
Figure 14a. Alul restriction patterns of S. aureus. Lanes 1 & 5- 
bacteriophage X/Pstl calibration standards; lane 6-bacteriophage 
X/Alul calibration standards; lane 2- 2 plasmid-bearing
MRSAH)(R); lane 4- 2 plasmid-bearing BC MSSA; lane 3- single 
small plasmid-bearing variant of isolate 18586. Photo of gel taken 
after running for 6 hours. Arrows indicate fragments derived from 
small plasmid.
1 2  3 4 5 6
e
Figure 14b. Same gel as shown in Figure 14a. Photo of gel taken 
after running for 18 hours.
variants. The aminoglycoside-sensitive MRSA showed more 
variety, with their larger plasmids varying between 17 and 26 kb. 
However more than 70% of the aminoglycoside-sensitive MRSA 
carried the same 23.2 kb plasmid, and Dice analysis suggested that 
the majority of the other large plasmids in this group were molecular 
variants of this plasmid. The large plasmids in the MSSA were 
clearly more heterogeneous; more than 30 different plasmids with 
sizes ranging from 14 to 51 kb were identified. Those MRSA and 
MSSA isolates that carried more than one plasmid harboured a small 
plasmid of 2.6 kb. These plasmids were indistinguishable regardless 
of their origin. The commonest plasmids from the MSSA isolates, 
as judged by restriction patterns, were present in both hospital and 
community isolates Figure 12).
COMPARISON OF BIOTYPING, IMMUNOBLOTTING, REFPS 
AND PHAGE TYPING OF MRSA(l)
The relationship between the results of the various typing 
methods was assessed. Table XI shows the biotype, immunoblot 
group, REFP group and phage type (RTD) of each of the isolates. 
There was strong positive correlation between BLOT1 and FP1 
groups, and between BLOT2 and FP2 groups (p < 0.001). In 
addition BLOT1/FP1 isolates were almost exclusively of biotypes A 
or C, whereas BLOT2/FP2 isolates were of biotypes B or D 
(p < 0.001) (Figure 15).
When phage typed, the BLOT1/FP1 strains were lysed by a 
selection of group 3 phages (predominantly 53, 83A and 85), the
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additional phages 8 8 A, 90, 83C and 932 and the "new" set for typing 
MRSA (particularly 616, 617, 622 and 626). In contrast the 
BLOT2/FP2 strains were poorly typed at RTD, and even at RTD x 
100 gave weak reactions to only a small number of phages (Phage 
typing data is presented in full in Appendix 2 ).
PATHOGENICITY FACTORS 
Enterotoxin Production
Table XII and Figure 16 summarise the results of RPLA 
testing for enterotoxins A, B, C and D. The data are shown 
separately for the MRSA isolates designated aminoglycoside- 
sensitive or aminoglycoside-resistant, in order to demonstrate 
differences between them.
Table XII. Distribution of enterotoxin production in isolates from
different sources
Enterotoxin
Number(%) of isolates 
producing enterotoxin
BC
(n=48)
GP
(n=46)
RD
(n=58)
MRSA(S)
(n=23)
MRSA(R)
(n=26)
A 17 (35) 20 (43) 18 (31) 19 (83) 5(19)
B 8(17) 4(9) 8(14) 3(13) 3(12)
C 9(19) 16 (35) 5(9) 3(13) 4(15)
D 7(15) 6(13) 4(7) 0 (0 ) 0 (0 )
The results of tests for each of the individual enterotoxins 
are considered in detail below, followed by an analysis of the pattern
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of enterotoxin production amongst the various collections. The 
enterotoxin results for individual isolates are presented in full in 
Appendix 3.
Distribution of individual enterotoxins 
Enterotoxin A
When the number of enterotoxin A positive isolates in each 
of the three MSSA sub-groups was compared, there was no 
significant difference (p > 0.5), and for the purposes of comparison 
with the MRSA these results were combined. The relative number 
of enterotoxin A producing isolates did not differ significantly in the 
MSSA (55/152) and aminoglycoside-resistant MRSA (5/26) groups. 
However the aminoglycoside-sensitive MRSA differed markedly 
from the others with 83 % (19/23) isolates producing enterotoxin A 
(p < 0 .0 0 1 ).
Enterotoxin B
The distribution of enterotoxin B positive isolates in each of 
the three MSSA sub-groups showed no significant difference 
(p > 0.5) and similarly, the distribution between aminoglycoside- 
sensitive and aminoglycoside-resistant MRSA collections was 
similar. When the combined MSSA results (20/152 enterotoxin B 
positive) were compared with the combined MRSA results (6/49 
enterotoxin B positive) no significant difference was demonstrated 
(p > 0.5).
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Enterotoxin C
No significant difference could be found in the distribution 
of enterotoxin C producers amongst the BC and RD MSSA 
collections. The proportion of positive isolates amongst these 
'’hospital” MSSA strains (14/106) did not differ from that found in 
either the aminoglycoside-sensitive (3/23) or aminoglycoside- 
resistant (4/26) MRSA sub-groups (p > 0.5). However significantly 
more enterotoxin C positive isolates (16/46) were found amongst the 
GP isolates than in either the combined BC and RD MSSA (14/106), 
or the combined MRSA (7/49) (p < 0.001).
Enterotoxin D
There was no significant difference in the number of 
enterotoxin D positive isolates in any of the MSSA sub-groups 
(p > 0.5), which were again combined for the purpose of comparison 
with MRSA isolates. None of the MRSA isolates produced 
enterotoxin D. The difference between the number of enterotoxin D 
positive isolates in the combined MSSA (17/152) and MRSA (0/49) 
collections was significantly different (p < 0 .0 0 1 ).
Distribution of enterotoxin-producing strains
Any isolate producing one or more enterotoxin(s) was 
defined an enterotoxin producer. Comparison of the relative 
numbers of enterotoxin producers in the various MSSA collections 
showed no significant difference (p > 0.5) (Table XIII).
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Table XIII. Comparison of numbers of enterotoxin producers and non­
producers amongst isolates from different sources
Number(%) of isolates
BC
(n=48)
GP
(n=46)
RD
(n=58)
MRSA(S) MRSA(R) 
(n=23) (n=26)
Producers 29 (60) 29 (63) 30(52) 20 (87) 7(27)
Non-producers 19 (40) 17 (37) 28 (48) 3(13) 19 (73)
There was a significant increase in the proportion of 
enterotoxin producers among the aminoglycoside-sensitive MRSA 
(20/23) when compared to the combined MSSA (88/152) 
(p < 0.001). However, significantly fewer enterotoxin producers 
were found among the aminoglycoside-resistant MRSA (7/26) than 
in either their aminoglycoside- or methicillin-sensitive counterparts
(p < 0 .0 0 1 ).
Table XIV. Comparison of multiple enterotoxin production by isolates
from different sources
Number(%) of isolates producing 
given number of enterotoxins
Toxins
produced
BC GP 
(n=48) (n=46)
RD
(n=58)
MRSA(S) MRSA(R) 
(n=23) (n=26)
0 19 (39) 17 (37) 28 (48) 3(13) 19 (73)
1 21 (44) 16 (35) 26 (45) 17 (74) 3(12)
> 2 8 (17) 13 (28) 4(7) 3(13) 4(15)
When the distribution of enterotoxins was examined in more 
detail by subdividing the isolates according to the production of 0 , 1  
or > 2  enterotoxins (Table XIV), the BC and GP MSSA
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distributions were found to be similar (p > 0.5). However, relatively 
fewer of the RD isolates produced > 2 enterotoxins with a 
concomitant increase in the number of single enterotoxin producers, 
although this difference only achieved statistical significance when 
compared with the GP isolates (p < 0.001).
Seventeen of the 2 0  enterotoxin positive aminoglycoside- 
sensitive MRSA were single enterotoxin producers. All 17 of these 
isolates produced enterotoxin A. In contrast, although the 
aminoglycoside-resistant MRSA were predominantly non- 
enterotoxin producers, more than half of those which were 
enterotoxin positive produced more than one enterotoxin. Thus the 
pattern of enterotoxin production of both aminoglycoside-sensitive 
and aminoglycoside-resistant MRSA differed markedly from that of 
the MSSA (p < 0.001) but for different reasons; the former group 
because of the vast preponderance of single enterotoxin A 
producers, the latter group as a result of the large number of non- 
enterotoxin producers (Figure 17).
Haemolysin Production
Table XV and Figure 18 summarise the results of tests to 
detect the production of a-, P-, y - and 6 -  haemolysins. In the 
interests of consistency with the presentation of results for 
enterotoxin production, the aminoglycoside-sensitive and the 
aminoglycoside-resistant MRSA isolates are again shown
89
\tv
O  OS
W\ \ V-\
3§BJUaDJ3J
Fi
gu
re
 
17
. 
D
ist
rib
ut
io
n 
of 
m
ul
tip
le 
en
te
ro
to
xi
n 
pr
od
uc
tio
n 
by 
St
ap
h,
 a
ur
eu
s 
fro
m 
di
ffe
re
nt
 s
ou
rc
es
.
Fi
gu
re
 
18
. 
Re
su
lts
 
of 
tes
ts 
for
 h
ae
m
ol
ys
in
s 
of 
St
ap
h,
 a
ur
eu
s.
separately, although there was no significant difference in the
distribution of haemolysin production between these two groups.
Table XV. Distribution of haemolysin production in isolates from
different sources
Haemolysin
Number(%) of isolates 
producing haemolysin
BC
(n=48)
GP
(n=46)
RD
(n=58)
MRSA(S)
(n=23)
MRSA(R)
(n=26)
a 28 (58) 27 (59) 31 (53) 15 (65) 21 (81)
P 9(19) 6(13) 15 (26) 8(35) 6(23)
Y 24 (50) 45 (98) 16 (28) 13 (57) 18 (69)
6 25 (52) 11 (24) 35 (60) 14 (61) 16 (62)
The results of tests for each of the individual haemolysins 
are considered in detail below, followed by an analysis of the 
distribution of haemolysin production among the various collections. 
The haemolysin results for individual isolates are presented in full in 
Appendix 3.
Distribution of individual haemolysins 
« -  haemolysin
Since the distribution of MSSA isolates which produced a -  
haemolysin did not differ between the BC, GP and RD sub-groups 
(p > 0.5), these were combined for comparison with the MRSA. 
Similarly the relative numbers of a -  haemolysin producers among 
aminoglycoside-sensitive and aminoglycoside-resistant MRSA sub­
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groups did not differ (p > 0.5). However, significantly more of the 
combined MRSA (36/49) produced a -  haemolysin than the 
combined MSSA (86/152) (p < 0.001).
3 -  haemolysin
No significant difference was detected in the relative 
number of p -  haemolysin producers amongst the various MSSA or 
MRSA sub-groups (p > 0.5). Similarly there was no difference in 
the relative combined total numbers of P - haemolysin producing 
MSSA (30/152) and MRSA (14/49) (p > 0.5).
Y- haemolysin
Considerably more GP isolates produced y - haemolysin 
than strains from either the RD or BC collections (p < 0.001). A less 
marked, but nonetheless significant increase was also apparent in the 
number of y -  haemolysin producers among the BC compared with 
the RD MSSA (p < 0.001). The proportion of y - haemolysin 
producers in the aminoglycoside-sensitive and aminoglycoside- 
resistant MRSA did not differ significantly (p > 0.5).
Sixty-three percent of MRSA (31/49), were y- haemolysin 
producers, a number similar to that of the BC MSSA (p > 0.5), but 
somewhat higher and lower than the RD and GP MSSA respectively 
(p < 0 .0 0 1 ).
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6 -  haemolysin
Significantly fewer GP than either BC or RD MSSA 
produced 5 -  haemolysin (p < 0.001). The BC and RD collections 
did not differ in this respect (p > 0.5). Similarly the 
aminoglycoside-sensitive and aminoglycoside-resistant MRSA did 
not differ significantly (p > 0.5). When the combined MRSA data 
(30/49) was compared with the combined BC and RD figures 
(60/106) as representing "hospital isolates" of MSSA there was no 
significant difference. However, it was clear that more MRSA 
produced 6 -  haemolysin than GP MSSA (p < 0.001).
Distribution of haemolysin-producing strains
Table XVI. Comparison of numbers of haemolysin producers and non­
producers amongst isolates from different sources
Number(%) of isolates
BC
(n=48)
GP
(n=46)
RD MRSA(S) MRSA(R) 
(n=58) (n=23) (n=26)
Producers 47 (98) 45 (98) 53 (91) 20 (87) 24 (92)
Non-producers 1 (2 ) 1 (2 ) 5 (9) 3 (13) 2 (8 )
The isolates were divided into haemolysin producers and 
non-haemolysin producers; haemolysin producers were defined as 
any isolate which produced one or more haemolysin(s). Comparison 
of the relative numbers of haemolysin producers in the various 
MSSA collections showed no significant differences (p > 0.5) 
(Table XVI), and the MRSA collections were similarly
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homogeneous. The relative total numbers of haemolysin producing 
MSSA (145/152) and MRSA (44/49) did not differ significantly 
(p > 0.5).
When the number of MSSA isolates in each of the BC, GP 
and RD sub-groups which produced < 2, 2 or >  3 haemolysins was 
compared, no significant difference could be demonstrated 
(Table XVII) (p > 0.5). Similarly, there was no significant 
difference between the aminoglycoside-resistant and 
aminoglycoside-sensitive MRSA sub-groups (p > 0.5)3. When the 
distributions of numbers of haemolysins produced by MSSA and 
MRSA were compared (Figure 19), these differed, with the MRSA 
producing significantly more haemolysins (p < 0 .0 0 1 ).
Table XVII. Comparison of multiple haemolysin production by isolates
from different sources
Haemolysins
produced
Number of isolates producing 
given number of haemolysins
BC
(n=48)
GP
(n=46)
RD
(n=58)
MRSA(S)
(n=23)
MRSA(R)
(n=26)
< 2 21 (44) 14 (30) 23 (40) 4(17) 4(15)
2 17 (35) 21 (46) 26 (45) 10 (44) 8(31)
> 3 1 0  (2 1 ) 11 (24) 9(15) 9(39) 14 (54)
3Due to the small numbers of MRSA isolates which produced less than 
two haemolysins, and in order to facilitate a valid statistical comparison, 
isolates producing 2  haemolysins were combined with those producing < 2  
haemolysins.
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CHAPTER 4
Discussion
94
ANTIBIOTIC RESISTANCE
The antibiotic-sensitivity test results with MRSA re­
emphasise that methicillin-resistant strains tend to be multiply 
resistant. Two antibiograms accounted for 94 % of all MRSA 
isolates, differing in the presence or absence of resistance to the 
aminoglycosides gentamicin, kanamycin and streptomycin, in 
addition to a "core” resistance to methicillin, penicillin, 
erythromycin and tetracycline present in all strains. These two sub­
groups determined by aminoglycoside sensitivity were similar to the 
sub-groups defined by other phenotypic and genotypic markers.
The results of the sensitivity tests with MSSA isolates were 
unremarkable and in keeping with expectations for this population.
One of the more interesting results of sensitivity testing was 
the demonstration of mupirocin resistance in one of the MRSA 
isolates (Baird and Coia, 1987). This strain was isolated before the 
introduction of mupirocin into clinical practice and was probably 
unrelated to prior use of this agent. Thus it demonstrates the 
potential for antimicrobial resistance to emerge by the selection of 
pre-existing mutants.
PREVALENCE AND DISTRIBUTION OF PLASMIDS IN MSSA
AND MRSA
The plasmids harboured by MSSA and MRSA differed in 
their prevalence, number and distribution. The most striking initial 
observation was that all MRSA harboured plasmids. This was in
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sharp contrast to the MSSA, in which more than half of the isolates 
were found to be plasmid-free. Although plasmid-free isolates of 
MRSA have been described by Gelmi et al (1987), most other 
studies report that the majority of MRSA do harbour plasmids.
The frequency distribution of plasmids in MRSA and MSSA 
isolates was markedly different. However, it was interesting to 
compare these distributions with those predicted by the model 
developed by Platt (1987) to analyse the distribution of plasmids 
amongst representative collections of enterobacteria. This model 
was based on previous observations that plasmid-free strains 
contributed disproportionately to the overall frequency distribution 
of plasmids in such collections. Therefore, in this model a modified 
Poisson distribution conditional upon n =j= 0 was used to predict the 
frequency distributions of plasmids in plasmid-containing strains. 
Such predictions agreed well with the distributions observed in this 
study.
The distributions predicted by the application of this model 
to the MSSA and MRSA collections are shown in Table XVIH. 
Amongst MSSA isolates, the observed frequency distribution of 
plasmids did not differ from the model prediction. What does this 
tell us about the MSSA? First, in line with the arguments advanced 
by Platt and co-workers, this suggests that the majority of plasmid- 
free MSSA isolates are poor plasmid recipients (Platt et al, 1984; 
Platt, 1987). Second, it supports the related hypothesis that the
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accumulation of plasmids by Gram-negative and Gram-positive
genera may be subject to the same variables.
Table XVIII. Comparison of observed plasmid distributions in MSSA 
and MRSA with distributions predicted by a modified Poisson model
Plasmids per 
isolate
Number of isolates with given no. of plasmids
MSSA MRSA
observed predicted observed predicted
62 63 12 47
10 8 85 32
0 0 3 15
0 0 1 6
The observed frequency distribution of plasmids from 
MRSA isolates differed significantly (p < 0.001) from that predicted 
by the model. The distributions were somewhat skewed, with a 
marked preponderance of isolates which harboured 2  plasmids. 
These findings were consistent with the hypothesis that the MRSA 
isolates represent dissemination of a limited number of clones within 
Glasgow Royal Infirmary.
COMPARISON OF MSSA AND MRSA REFPS
The REFPs from the MRSA isolates were markedly less 
diverse than amongst the MSSA. As has been shown (p. 79), 
application of Dice analysis to the observed HaeIII patterns 
demonstrated two major groups of MRSA, FP1 and FP2. The 
majority of isolates in each of these groups yielded an identical
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"prototype" pattern, with other isolates in the groups exhibiting 
greater or lesser degrees of variation from these. This variety arose 
from two distinct sources. First, the presence or absence of the 
uncut small plasmids which yielded characteristic changes to the 
REFP. The resultant alteration to the REFPs was thus the result of a 
discrete change in number of plasmids harboured. The second 
component to REFP variability in each of the major MRSA REFP 
groups was molecular rearrangements in the larger MRSA plasmids. 
This phenomenon produced either loss of DNA fragments from the 
respective prototype pattern and/or the presence of extra DNA 
fragments additional to the group prototype.
It has been noted that the large plasmids in aminoglycoside- 
resistant MRSA were less variable than in their aminoglycoside- 
sensitive counterparts. It is interesting to speculate whether this 
relative lack of diversity reflected their somewhat more 
circumscribed epidemiological distribution within the hospital; 
aminoglycoside-resistant MRSA are largely, although not 
exclusively, isolated from the Burns and related units.
Comparison of the MRSA(l) and MRSA(2) isolates was 
largely unremarkable. The same basic patterns were observed, and 
there was no evidence amongst the MRSA(2) of either radical 
rearrangement of the plasmids found in MRSA(l) or the presence of 
novel large plasmid species. Small plasmids were homogeneous as 
described already.
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Thus, the majority of MRSA harboured two plasmids. 
These plasmids comprised a small 2.6 kb species common to all 
MRSA isolates, and variants of a larger plasmid of either 18.3 kb or 
23.2 kb in aminoglycoside-resistant and aminoglycoside-sensitive 
strains respectively. The few MRSA isolates which harboured more 
than 2  plasmids shared variable numbers of common fragments with 
the prototype MRSA REFPs, although it is not surprising that their 
Dice co-efficients of similarity were lower as a result of the extra 
DNA fragments yielded by the digestion of the additional plasmids.
The MSSA REFPs were more diverse than the MRSA. The 
combined REFP and profile data were consistent with them 
harbouring more than 30 plasmids in the range 14.5 - 50.7 kb. It is 
clear that this was an important "third factor" in the generation of 
diversity, additional to the two factors outlined above for the MRSA 
sub-groups.
Common REFPs and plasmids were found both within and 
between the various MSSA sub-groups. It seems likely that this
i
reflected interchange of strains although, of course, it may have been 
the result of exchange of plasmids. MRSA REFPs were not found 
amongst the MSSA, although some DNA fragments, most notably 
the 2.7 kb HaeIII fragments, were shared between the two groups.
An issue which is debated frequently when considering 
epidemiological data based on plasmid studies is the relative 
instability of such elements. In the course of this study a number of
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isolates were re-examined after prolonged storage (> 1 2  months) and 
repeated sub-culture (20-30 passages). It was reassuring that the 
results of these experiments showed that there was good stability in- 
vitro. A  more interesting observation when comparing the 
MRSA(1) and MRSA(2) collections was that this stability could be 
demonstrated in-vivo because these isolates had been collected over 
an extended time period. This stability has not been found in 
preliminary studies of Staphylococcus epidermidis which suggests 
that whereas these plasmids may be stable in-vitro major molecular 
re-arrangements may take place in-vivo within a very short time (J. 
Coia, unpublished data). This difference between two 
staphylococcal species highlights the fact that the application of 
plasmid data to epidemiological questions requires the establishment 
of a proper interpretative framework on a species by species basis. 
Indeed such considerations of applicability and stability of typing 
characteristics should be explored rigourously for any novel or, for 
that matter, existing technology.
ORIGINS OF MRSA WITHIN GRI
When taken together the plasmid distribution data and the 
limited REFP diversity of MRSA argue strongly in favour of clonal 
dissemination within the hospital, but the question of the original 
source of the MRSA remains unanswered. One possibility is, that it 
was exogenous with subsequent spread favoured by selection 
pressure. An example of such a process has been elegantly 
documented in Dublin hospitals (Carroll et al, 1989). Such a model
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is attractive in explaining the origin and evolution of the current 
MRSA epidemic. However, the large number of geographically 
distinct isolations of MRSA organisms which behave very 
differently in terms of microbiological and clinical characteristics, 
within a relatively short space of time raises the possibility that 
MRSA may have evolved locally from endogenous MSSA strains.
This alternative hypothesis is supported by some of the data 
presented here, particularly the finding that the small multicopy 
plasmids are identical in both MSSA and MRSA. Many of the 
isolates of MRSA from patients in different hospitals in England, 
and which have been described as epidemic MRSA (EMRSA) 
(Cookson et al, 1986), carry small plasmids similar in size to those 
of the local MRSA as described here. However, their REFPs 
(Figure 8 , p. 78) differed markedly from those of local MRSA. In 
addition, the small plasmids harboured by MRSA and MSSA from 
this hospital are indistinguishable, but differ from small plasmids of 
EMRSA. These facts are all in favour of the local evolution de novo 
of local MRSA from methicillin-sensitive strains.
The most likely progenitor strain for such a process would 
be a two plasmid-bearing MSSA. However, such isolates were rare 
amongst MSSA strains, and the small number of such isolates 
studied in this collection does not preclude the existence of such 
progenitors, which would be expected to yield REFPs more similar 
to their methicillin-resistant counterparts.
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The two hypotheses for the origin of MRSA are not 
mutually exclusive; both processes may have occurred in different 
locations at different times. Regardless of source, exogenous or 
endogenous, the same balance of positive and negative selection 
pressures would influence subsequent spread and evolution within 
an institution. A  further finding which requires consideration is the 
relationship between the two major MRSA REFP groups; either 
there was a single MRSA clone which diverged early to give rise to 
these distinct patterns or two separate events established the separate 
clones. It is not possible to give a definitive answer to this question, 
but the marked differences in REFP, together with the differences 
demonstrated by the other typing methods, all of which must have 
developed during the relatively short period during which MRSA 
have been present in the hospital, favour the latter explanation. The 
alternative possibility requires the very rapid divergence of a single 
clone, which seems less likely given the very similar environments 
in which such a process would have to have occurred.
COMPARISON OF CHARACTERISATION OF MRSA BY
BIOTYPING, IMMUNOBLOTTING AND REFPS
One of the aims of this study was to explore to what degree 
the information derived from different methods could usefully be 
combined in an epidemiological context. It was not intended to 
establish a definitive method for the typing of MRSA. Clearly each 
of the methods described has associated strengths and weaknesses. 
The methods adopted by any individual centre to monitor the spread
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of MRSA will ultimately be determined by local expertise and 
experience, available facilities and prevailing resource constraints.
Biotyping is attractive, because it is simple, quick and 
reproducible, and can easily be incorporated into the daily bench 
routine of a diagnostic clinical microbiology laboratory. However, 
in the scheme described here, due to the limited number of 
characteristics tested, strain discrimination was limited. It may be 
that the incorporation of additional tests, such as those for 
haemolysin or enterotoxin production, would increase 
discrimination. However, this would detract from the major virtues 
of low cost and simplicity. A further consideration concerns the 
wider applicability of the scheme utilised here. Although this 
biotyping method was very useful in epidemiological monitoring 
within GRI and its associated hospitals, such a simple scheme on its 
own may not have the same value in the analysis of a broader-based 
collection of Staph, aureus strains.
Phage typing is standardised, reproducible and universally 
acknowledged as a definitive method for the investigation of 
outbreaks of infection with Staph, aureus (Parker, 1983). It is rapid 
to perform and apparently relatively inexpensive to perform, but 
there are hidden costs in the maintenance of stocks of phages. In 
addition, the best and most reproducible results are those from 
reference centres which may be geographically remote from the 
laboratories in which the organisms have been isolated. However, 
the most important drawback with respect to MRSA is that the
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organisms may be poorly lysed by phage, or not at all. This was a 
problem encountered with significant numbers of the isolates studied 
here.
Immunoblots, either of whole-cell or exported proteins, 
have been used increasingly in the epidemiological investigation of 
outbreaks of infection (Lee et al, 1986; Burnie et al, 1988; McKay et 
al, 1988). The characteristic profiles produced provide a rapid, 
reproducible and sensitive method for characterisation of a range of 
organisms using the same apparatus and techniques. Furthermore, 
all the antigenic polypeptides of each isolate can potentially 
contribute to the immunoblot profile, rather than relying on the 
expression of a limited number of biological, biochemical or 
morphological characteristics. However capital costs are 
undoubtedly high, and specialist technical expertise is required. If 
immunoblotting was to be employed on a wider scale, with analyses 
performed at a number of centres, standardisation of reagents and 
the methods used to document results would be required to allow 
inter-centre comparability of the data generated (Hawkey, 1987).
REFP analysis shared many common advantages and 
disadvantages with immunoblotting. This technology removes 
completely the requirement for phenotypic expression to facilitate 
typing, and indeed variations in the entire genome of the organism, 
including non-coding regions, are amenable to analysis. Since all 
diversity ultimately derives from alterations to an organisms DNA, 
this is the most fundamental level at which to study such variation.
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Disregarding cost and expertise, and these considerations should 
become less important with advances in technology and automation, 
the major problem that remains is how to compare data from 
different laboratories. Many of the interpretative problems could be 
solved by the adoption of standardised restriction enzyme digestion 
strategies (Platt et al, 1986).
Perhaps the most interesting finding in this study was the 
general agreement between the results generated by these disparate 
typing methods. Not only did the techniques mutually validate one 
another, but each method, in a more or less direct fashion, 
demonstrated differences arising from a limited number of 
underlying genotypes. Clearly there were two major groups of 
isolates:- FP1 / Biotype (A+C) /  BLOT1 and FP2 /  Biotype (B+D) / 
BLOT2 (Figure 15). Moreover, most strains in the former group 
produced enterotoxin, whereas strains in the latter tended not to do 
so. It was not possible to conclude if the small number of isolates in 
the BLOT3 and FP3/4 groups represented other distinct subgroups, 
and the investigation of further isolates would be necessary to clarify 
this.
The various techniques differed in their ability to 
discriminate between individual isolates. Categorisation into four 
biotypes proved a very useful tool within the hospital for day-to-day 
assessment and clinical monitoring of the spread of MRSA, but 
supplementary methods such as immunoblotting and REFP analysis 
provided the "fine tuning" discrimination which is of value in the
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detailed investigation of the origins and spread of infection with 
these organisms. The increased diversity revealed by these 
techniques is of benefit in these circumstances. The benefit of a 
quantitative approach to the assessment of strain relatedness, by 
means of Dice analysis, was considerable. Such methods reduce 
reliance on subjective evaluation of similarity with all its 
concomitant disadvantages.
All of the methods, with the exception of phage typing were 
able to type all the isolates. This is in agreement with the findings 
of Gaston and his co-workers (Gaston et al, 1988) who have 
previously found this to be the case for a variety of electrophoretic 
methods. Plasmid-free MRSA would naturally have been untypable 
by REFP analysis of plasmid DNA, but in such an event REFP 
analysis of chromosomal DNA could be used. (Hall and Jordens, 
1988).
This study endorsed the findings by Cookson that the use of 
a combination of techniques yielded a breadth of epidemiological 
information which provided a clearer picture of the disposition of 
MRSA within the hospital (Cookson et al, 1986). The corroboration 
between the essentially disparate methods used in this study 
illustrates a number of interesting features of MRSA. First, they 
support the previous proposal that MRSA endemic in Glasgow 
Royal Infirmary are derived from two major clones. Second, the 
strain discrimination afforded by each method individually, indicates 
strain divergence in terms of both chromosomal and
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extrachromosomal DNA. The parity between methods shows that 
neither strain nor plasmid shows independent instability. Data from 
both REFP analysis (extrachromosomal) and Western blots of 
exported proteins (predominantly chromosomal) strongly suggest 
that the two clones are diverging at different rates on the basis of 
inter-group differences and intra-group similarities. The 
predominant association of each of the two clones with different 
clinical units raises the intriguing possibility that the different 
divergence rates reflect differences in the selection pressures in the 
respective units, and may warrant further investigation.
The results obtained from the combination of methods 
described here suggests the potential for a strategic approach to the 
study of the epidemiology of MRSA. Simple biotyping could be 
employed to monitor large numbers of isolates. The increased 
resolution of the more detailed analytical techniques could then be 
focussed upon selected representative samples from therein. In this 
way maximum information could be derived from minimum 
expenditure of time, effort and money.
This work has attempted to examine MRSA in their proper 
epidemiological context. Particular emphasis has been placed on the 
analysis of plasmid DNA, and the results of these analyses have 
been related to information about a number of other properties of 
MRSA. The amount of epidemiological information yielded by 
combining the results of plasmid analysis with those from other 
techniques has provided a clearer picture of the nature of MRSA
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within GRI. It seems certain that two major clones of MRSA are 
present within the hospital which demonstrate a number of 
differences in the various properties studied. What of the origins of 
these clones? The small plasmid data supports the view that these 
organisms evolved locally, although introduction from an exogenous 
source remains a possibility. But regardless of ultimate origin, 
either there was a common progenitor of the 2 major MRSA clones, 
or each arose from separate unique events to establish a separate 
lineage. MRSA isolates with properties which suggest they 
belonged to the aminoglycoside-sensitive group were first isolated 
during 1983 in GRI. Isolates of aminoglycoside-resistant MRSA 
were first encountered early in 1984. Thus if divergence from a 
common progenitor did occur, it must have been a fairly early event. 
Given the observed differences in a number of properties, it may 
well be that similar selection pressures at around the same time 
resulted in the establishment of two separate clones. It is unlikely 
that there will ever be an irrefutable answer because the original 
isolates are unfortunately unavailable for study to assess the degree 
of dissimilarity present at that time.
PATHOGENICITY FACTORS 
ENTEROTOXIN PRODUCTION
The production of enterotoxin has been recognised 
increasingly as an important determinant of virulence in Staph, 
aureus. These biologically active substances, particularly
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enterotoxins A  and B, have been implicated in the pathogenesis of a 
number of clinical syndromes associated with staphylococcal 
infection. Their precise role in the majority of these syndromes 
remains to be elucidated. The main findings with regard to 
enterotoxin production in this study can be summarised as follows.
MSSA ISOLATES
If the pathogenicity of Staph, aureus is related to the 
production of enterotoxins it might be expected that isolates from 
"serious" infection episodes such as septicaemia, would be more 
likely to yield enterotoxins. Humphreys and his co-workers in 
Dublin have shown previously that more than 63 % of 52 blood 
culture isolates studied by them produced enterotoxins A, B, C or D 
either alone or in combination, whereas only 11 % of 27 nasal 
carriage isolates yielded enterotoxin, and in every case enterotoxin 
D alone (Humphreys et al, 1989). In this study 29/48 (60 %) of 
septicaemia (BC) isolates produced enterotoxins. This finding is in 
close agreement with their experience and the distribution of 
individual enterotoxins is similar (Table XIX). However, the 
findings for the nasal carriage isolates were strikingly different; 
29/46 (63 %) of the Glasgow isolates produced at least one 
enterotoxin, although, as in Dublin, this was usually enterotoxin D.
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Table XIX. Distribution of enterotoxin production in isolates from 
different sources: Dublin and Glasgow compared
Number(%) of isolates 
producing enterotoxin
Septicaemia Nasal carriage
Enterotoxin Dublin
(n=52)
Glasgow
(n=48)
Dublin Glasgow 
(n=27) (n=46)
A 15 (29) 17 (35) 0 (0) 20 (43)
B 1 1  (2 1 ) 8(17) 0 (0) 4 (9)
C 16 (31) 9(19) 0 (0) 16 (35)
D 10 (19) 7(15) 3(11) 6(13)
The phenotypic characteristics of the septicaemia isolates 
with regard to enterotoxin production were very similar in the 
isolates from both studies, and this may well reflect some enhanced 
propensity to produce invasive disease. The marked disparity in the 
ability of nasal carriage isolates to produce enterotoxin was 
intriguing. Firstly, it demonstrates that nasal carriage isolates from 
geographically distinct locations do not express this characteristic 
homogeneously, and underlines the need to establish an appropriate 
local representative collection of organisms when making 
comparisons. Secondly, it suggests that even if enterotoxin 
production is associated with enhanced pathogenicity, the ability of 
Staph, aureus to produce disease depends on other factors as well.
The proportion of enterotoxin producers amongst the RD 
Staph, aureus isolates (52 %) was slightly lower than amongst the 
BC and GP isolates (60 % and 63 % respectively), but not
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significantly so. The distribution of the individual enterotoxins was 
again similar. However Jordens and co-workers did not detect 
enterotoxin production in any of ten clinical isolates of MSSA from 
the London Hospital (Jordens et al, 1989).
When the results from the BC isolates are considered it is 
not surprising that significant enterotoxin production is so common 
in other clinical isolates. Many of the septicaemic episodes were 
hospital acquired and consequently the organisms involved would 
form a subset of those found in other clinical lesions from patients 
within the hospital. It may be that the higher proportion of BC 
isolates that produced enterotoxins A, B, C and D when compared 
with other strains would have attained statistical significance if the 
sample size had been larger, and that enterotoxin production may be 
related to the invasive capabilities of these organisms. Conversely, 
it could be argued that other factors, unrelated to enterotoxin 
production are of most importance in determining the ability of an 
organism to produce septicaemia. None of the patients whose 
organisms made up the RD collection subsequently developed 
Staph, aureus septicaemia.
MRSA ISOLATES
A number of studies have suggested that enterotoxins may 
contribute to the pathogenicity of MRSA. Duckworth and 
Oppenheim (1986) described an association between the production 
of enterotoxins A and B and the pathogenesis of an illness
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resembling toxic shock syndrome in two patients infected by 
EMRSA. All of 9 MRSA isolates from episodes of septicaemia in 
Dublin hospitals were found to produce enterotoxins A and B, either 
alone, or in combination (Humphreys et al, 1989). Jordens and co­
workers have recently described the production of enterotoxin A 
alone in all of 6  EMRSA isolates studied (Jordens et al, 1989).
Enterotoxin production by aminoglycoside-sensitive MRSA 
in Glasgow Royal Infirmary reported in this study is very similar. 
Nineteen of twenty-three isolates (83 %) were enterotoxin A 
producers. Two of these isolates also produced enterotoxins B and 
C; a third elaborated enterotoxins B and C only. However, the data 
for the aminoglycoside-resistant MRSA were rather different. 
Nineteen of twenty-six isolates (73%) did not produce enterotoxins 
at all. Of the seven isolates which did produce enterotoxin, three 
isolates produced enterotoxin A alone, two isolates enterotoxins B 
and C, one isolate enterotoxins A, B and C, and one isolate 
enterotoxins A and C.
This difference between our results and those from other 
centres was interesting. It reinforces the idea, discussed elsewhere 
with regards to plasmid, biotype, immunoblot and phage type data, 
that there are two predominant clones of MRSA within the hospital; 
the enterotoxin A producing aminoglycoside-sensitive isolates and 
the predominantly non-enterotoxin producing aminoglycoside- 
resistant strains.
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MRSA AND MSSA COMPARED
In the light of the marked differences in enterotoxin 
production between the aminoglycoside-sensitive and 
aminoglycoside-resistant MRSA, it was logical to consider each of 
these sub-groups separately when comparing the results with those 
of the MSSA. Enterotoxin production by the MSSA sub-groups was 
rather homogeneous, with the exception of the GP isolates which 
tended to have more enterotoxin C producers.
The significantly increased proportion of enterotoxin 
producers in the aminoglycoside sensitive MRSA was almost wholly 
due to the large number of strains that produced enterotoxin A. This 
increase in enterotoxin A producers, amongst MRSA isolates 
compared to MSSA, although less marked in the present work, is 
characteristic of the findings of previous studies (Humphreys et al, 
1989; Jordens et al, 1989). However, the finding that enterotoxin 
production by aminoglycoside-resistant MRSA was less common 
than by MSSA was most intriguing. MRSA in GRI have been found 
to be efficient colonisers but have caused relatively few episodes of 
serious infection, which have usually been due to aminoglycoside- 
sensitive organisms (D R Baird, personal communication). 
Considering the small numbers of infections, the wide differences in 
the patients’ underlying diseases, and the variety of other factors 
involved, it would be unwise to draw any firm conclusions from this 
association, but it is an area which merits further study in the future.
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The most remarkable feature regarding enterotoxin 
production between the various collections was the difference in the 
number of strains elaborating enterotoxin A. Enterotoxin B 
production was remarkably homogeneous, regardless of the origin of 
the isolates. Hospital isolates of Staph, aureus were also consistent 
with regard to enterotoxin C although there was a small, but 
significant, increase in GP isolates producing this toxin. The 
complete absence of enterotoxin D producers amongst the MRSA 
isolates is interesting when the origin of these isolates is considered. 
Some of the results of this study have suggested that one or both 
MRSA clones may have been derived by local evolution from 
methicillin-sensitive strains. If this is so, it would have been 
expected to find some enterotoxin D producers amongst the MRSA. 
However the results do not preclude the existence of an enterotoxin 
D producing progenitor strain, which is either not present in this 
sample, or no longer demonstrates this phenotype due to loss of 
DNA or failure of expression.
HAEMOLYSINS
The Staph, aureus haemolysins, a-, p-, y - and 6 -  are 
thought to exert their pathogenic effects by direct damage to cell 
membranes. They exhibit potent biological activity in vitro, and this 
is thought to reflect an important contribution by these toxins to the 
overall pathogenicity of isolates of Staph, aureus. The information 
obtained from the current study with regard to haemolysin 
production was considered as follows.
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MSSA
In view of their cytotoxic effects, it might be expected that 
organisms isolated from septicaemic episodes would be more likely 
to elaborate haemolysins. Indeed, Humphreys (1989) has shown 
that in such isolates from Dublin hospitals, the frequencies of a -, y - 
and 6 -  haemolysin production are in excess of 80%. In the current 
study, although slightly more p -  haemolysin producers were found, 
the figures for the other haemolysins were considerably lower (Table 
XX). However, the figures for a -  and y - lysin were in closer 
agreement with those of Christenssen and Hedstrom (1986) based on 
a study of 8 8  septicaemia isolates of Staph. aureus which yielded 
figures of 58% and 24% respectively. Whilst the Dublin group 
found little difference in the frequency of haemolysin production in 
septicaemia and nasal carriage isolates, the current study identified 
substantially higher and lower numbers of y - and 6 -  lysins 
respectively in the carriage group (Table XX).
With the exception of a very low frequency of y - lysin 
production (28%), the distribution of haemolysin production in the 
RD group was similar to that of their hospital septicaemic 
counterparts, which again may reflect the fact that the BC isolates 
form a subset of the RD collection.
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Table XX. Distribution of haemolysin production in isolates from 
different sources: Dublin and Glasgow compared
Number(%) of isolates 
producing haemolysin
Septicaemia Nasal carriage
Haemolysin Dublin
(n=52)
Glasgow
(n=48)
Dublin
(n=27)
Glasgow
(n=46)
a 43 (83) 28 (58) 25 (92) 27 (59)
P 3(6) 9(19) 3(11) 6(13)
Y 49 (94) 24 (50) 25 (93) 45 (98)
6 49 (94) 25 (52) 25 (93) 11 (24)
MRSA
Both Jordens and Humphreys have previously shown that 
all, of five and nine isolates respectively, of MRSA which they 
tested produced a-, y - and 6 -  haemolysins, whilst none elaborated 
p -  lysin (Jordens et al, 1989; Humphreys et al, 1989). Whilst 
frequencies of haemolysin production, and particularly multiple 
haemolysin production, tended to be higher in MRSA from GRI than 
in other hospital isolates, the numbers of a -  (73%), y - (63%) and 6 -  
(61%) lysin producers were not as high as in the Dublin and 
EMRSA studies. However, in contrast with these other studies, 28% 
of GRI MRSA isolates elaborated p -  lysin.
Unlike the situation with regard to enterotoxin production, 
there were no marked differences in the frequencies of haemolysin
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production in the aminoglycoside-sensitive and aminoglycoside- 
resistant MRSA groups.
MRSA AND MSSA COMPARED
The differences between the MSSA and MRSA with regard 
to haemolysin production reflected the tendency for the latter group 
to produce more haemolysins and to produce multiple haemolysins. 
a -  haemolysin particularly was produced with higher frequency 
than in any of the MSSA collection. The slight increase in (3- lysin 
producers amongst the MRSA did not reach significant levels, 
although there were clearly more 6 -  lysin producers amongst MRSA 
than amongst the RD MSSA. Whilst the similar frequencies of y - 
lysin production in the MRSA and BC MSSA collections were 
significantly higher than in the RD MSSA, the very high frequency 
of y - lysin producers amongst the community isolates was much 
greater than in any of these other groups.
GENERAL CONSIDERATIONS
Clearly the results of tests for pathogenicity factors in Staph, 
aureus demonstrated a number of similarities with previously 
published data, as well as some important differences. The major 
differences concern the RD MSSA and the MRSA data.
The GP MSSA data do not support the model of a simple 
relationship between enterotoxin and haemolysin production and 
pathogenicity. Enterotoxin production frequencies were very similar
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to, and haemolysin production frequencies only marginally lower 
than, their counterparts from clinical infection episodes; enterotoxin 
C and y - lysin frequencies were in fact significantly higher.
Amongst the MRSA, the aminoglycoside-sensitive isolates 
behaved in a very similar manner to their methicillin-resistant 
counterparts from elsewhere; high frequencies of enterotoxin A 
production were coupled with high frequencies of haemolysin 
production. However, while the aminoglycoside-resistant MRSA 
were indistinguishable with regard to haemolysin production, their 
very low frequency of enterotoxin production was quite different.
A  thorough understanding of the mechanisms whereby 
microorganisms exert their pathogenic effects will play an 
increasing role in the development of strategies to combat microbial 
disease . Whilst "classical" exotoxin medicated diseases, such as 
tetanus or botulism are relatively straightforward to comprehend in 
terms of the extremely potent biological activity of individual toxins, 
these represent one end of a wide spectrum. At the other end of that 
spectrum organisms, hitherto regarded as innocuous and ill-equipped 
as pathogens, may result in overwhelming infections in the 
increasing numbers of compromised hosts in our hospitals. Between 
these extremes lie all shades of complexity of interactions between 
the host immune system and microbial pathogenic mechanisms.
There is little doubt that the enterotoxins and haemolysins of 
Staph, aureus are toxins of not inconsiderable potency. Equally in a
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situation where all three MSSA groups produced these toxins with 
similar frequency there must be other factors which determined 
whether an individuals experience of the organism resulted in 
asymptomatic carriage or fatal septicaemia. These factors would 
have included other toxins and enzymes produced by the organisms, 
opportunity for deeper tissue invasion , humoral and cellular 
immune status, nutritional status, age and underlying disease of the 
patient. This multitude of variables confounds attempts to 
understand pathogenicity in terms of properties of the organism 
alone.
To some extent animal studies and in vitro systems can help 
us to standardise the relative pathogenic potential of organisms. In 
the long term it must be hoped that such studies in conjunction with 
an increased knowledge of immune mechanisms and quantitation of 
those factors which render our individual susceptible to infection 
will allow us to relate the properties of an organism to the disease 
produced in patients.
FUTURE DEVELOPMENTS
A continuation of the study to seek any further divergence 
and monitor the evolution of MRSA within GRI will be valuable. A 
longitudinal component was inherent in the design of this study, and 
it was clear that at the plasmid level there was some degree of 
stability. However, biotyping of more recent isolates has
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demonstrated some increase in diversity (Dr D R Baird, personal 
communication).
The ecology of these strains is complex. This work has 
provided baseline data for the existing populations of MSSA and 
MRSA and, in addition, has established the analytical and 
interpretative framework for the further study of the MRSA. A 
strategic approach to the study of the evolution of these organisms 
within the hospital using a combination of conventional 
microbiological and molecular biological techniques is now 
possible.
Automation will facilitate the application of molecular 
methods to the analysis of epidemiological problems. Already 
commercial systems to perform rapid, automated immunoblotting 
are available, and have been used to provide answers to 
epidemiological questions (Stephenson et al, 1986). This 
technology will be used more widely to deal with the increasing 
problems of nosocomial infection and further developments in 
automation will inevitably encompass nucleic acid techniques, 
including plasmid profiles and REFPs. Automated and semi­
automated molecular techniques are available now as diagnostic 
tests, and their extension into epidemiology is a natural progression. 
As automation decreases the demands on resource and expertise, 
molecular techniques in clinical microbiology will increase, and they 
will no longer be regarded as research methods. As has been shown 
in this study, it will be necessary to ensure adequate reference is
120
made to representative collections of organisms from appropriate 
"background” populations, rather than focussing on "outbreak" 
isolates alone, if valid comparisons are to be made.
One area worthy of particular attention is the development 
of more sophisticated analytical techniques. The availability of high 
performance densitometry systems and cheap, powerful 
microcomputers will permit the establishment and interrogation of 
large databases derived from protein and nucleic acid 
electrophoresis results. This will be an essential prerequisite for 
significant expansion in the use of these techniques, as it is time 
consuming and error-prone to make comparisons between isolates at 
present, particularly where either the numbers of strains and/or 
fragments involved is large or the strains do not appear on the same 
gel. To allow for variations in running conditions between one gel 
and another, particularly when comparing data from different 
centres, would require the incorporation of agreed standards in each 
gel. Indeed, to allow for the discontinuities within a single gel, it 
may even be necessary to include standards in many, if not every, 
track of the gel. In the latter case a further problem would be the 
need to differentiate the standards from the sample material. This 
internal standardisation would be required in addition to any agreed 
standardisation of protocols for restriction digestion schemes or 
preparation of antisera for immunoblotting, as have already been 
discussed.
121
Even if all these criteria are met, there is still a need to 
develop better methods for the quantitative analysis of the similarity 
of patterns generated by electrophoresis. The Dice co-efficient of 
similarity (Dice, 1945) has been used in this and other studies (Coia 
et al, 1990, Thomson-Carter and Pennington, 1989). Fourier 
transforms have been employed to quantitate similarity of 
immunoblots (Stephenson et al, 1986). However, it seems likely 
that improvements in these systems will be developed, utilising 
more sophisticated computer analysis. In addition, more specific 
features of the systems under study might be considered. For 
example, consider Dice analysis of the two hypothetical sets of 
REFPs of 2 different plasmids illustrated in Figure 20. In the 
comparison of the two plasmids in pair (a) the Dice co-efficient is:-
2 x 4
SD = ---------  x 1 0 0 % = 88.9 %
9
In the second pair (b), the Dice co-efficient is:- 
2 x 4
SD = ---------  x 100% = 88.9 %
9
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Figure 20. Restriction enzyme fragmentation patterns of two 
hypothetical related plasmids (a) and (b).
Since, the fragments in each lane are the digest products of a 
single plasmid, unlike the results of protein electrophoresis, where 
each band in a lane represents a discrete polypeptide, the molecular 
weight of the plasmid is equal to the sum of the fragment weights. It 
is therefore possible to deduce what proportion of the total plasmid 
molecular weight is contributed by each fragment, and to propose a 
modification of the Dice co-efficient whereby similarity (S) is:-
2  x mol wt of matching fragments
S = ..............................................................................  x 100%
mol wt of frag’s in A  + mol wt of frag's in B
When we apply this to the hypothetical REFPs the similarity 
of pair (a) now becomes
36
Similarity = — x 100 % = 83.7 %
43
and for the second pair (b):- 
46
Similarity = — x 100 % = 95.8 %
48
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This method takes more account of the relative contributions 
of larger and smaller fragments to the overall dissimilarity of the 
plasmids being compared. Clearly this system has limitations; it can 
only be used to compare single plasmid isolates, or single plasmids 
which have been segregated into plasmid free recipients. It is not 
particularly useful for chromosomal fingerprinting, because the large 
number of fragments and the difficulty of calculating accurately the 
total chromosomal size preclude calculation of the relative 
contributions of individual fragments. However, this is an example 
of how mathematical manipulations which take account of the 
underlying nature of the system may be employed in attempts to 
develop more discriminatory comparative indices.
It would be interesting to examine further the highly 
conserved small plasmids from the MRSA in GRI and to compare 
these more closely with other small plasmids found in Staph, aureus. 
The 2.7 kb HaeIII restriction digest fragment is also intriguing. It 
would be interesting to clone this fragment and to use it to probe 
staphylococcal genomic DNA, and plasmids from other species, to 
establish how ubiquitous it is. One possibility is that it is involved 
in the encoding of some common function, another that it may be 
part of a regulatory or recognition sequence.
Chromosomal fingerprinting of Staph, aureus would be a 
logical extension of this study. Some preliminary work has been 
done using a modification of the method previously described for 
Vibrio cholerae (Mekalanos, 1983)(Figure 21).The results should be
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Figure 21. Pstl chromosomal fingerprints of Staph, aureus. Lanes 
1-6 -strain 08886 (RD MSSA); lanes 7-12 -strain 18086 
(MRSA(1)(R)).
particularly useful for the MSSA because more than half of the 
isolates were plasmid-free, and this precluded the use of plasmid 
REFPs as an epidemiological tool. Not surprisingly the number of 
fragments generated is very large, but more specific discrimination 
could be achieved, either by examining specific molecular size 
ranges, or by employing techniques such as field inversion gel 
electrophoresis to obtain better fragment resolution. In addition, 
Southern blotting using probes which recognise common repeated 
sequences, particularly ribosomal DNA genes, has been employed 
very successfully to examine the epidemiology of outbreaks of 
infection with a variety of organisms (Irino et al, 1988; Grimont et 
al, 1989).
Future investigation of pathogenicity determinants, could 
include the examination of various other toxins such as TSST-1, 
staphylokinase production and levels of coagulase production. 
However, the pathogenesis of staphylococcal disease is a very 
complex process, and development of our understanding of the 
factors involved is more likely to depend on elucidating the precise 
modes of action of the various components which contribute towards 
pathogenicity, than on extending the list of toxins and enzymes 
produced. This will require more sophisticated models of the 
pathogenic process in order to assess in greater detail the relative 
contributions of the various bacterial factors involved, and in 
addition aim to increase our understanding of the immune system 
and its interaction with the invading micro-organism.
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CHAPTER 5
Conclusions
126
1) There were no differences in the prevalence, number or 
distribution of plasmids harboured by hospital and 
community isolates of MSSA.
2) There were significant differences in the prevalence, number 
and distribution of plasmids harboured by MSSA and 
MRSA. All MRSA harboured plasmids, whereas more than 
50 % of MSSA were plasmid free.
3) Isolates with more than 1 plasmid were rare amongst 
plasmid-bearing MSSA, but represented the majority of 
MRSA; 85 % of MRSA harboured 2 plasmids.
4) The frequency distribution of plasmids in MSSA agreed 
well with that predicted by the modified Poisson model for 
plasmid distributions; the MRSA distribution did not fit the 
model and was consistent with the dissemination of a 
limited number of clones within the hospital.
5) Two size groups of plasmids, large and small, were 
detected. In MRSA the large plasmids comprised two main 
species and their molecular variants. The large MSSA 
plasmids were more diverse. The large plasmids found in 
MRSA and MSSA were different, but the small plasmids 
were identical irrespective of source.
6 ) There were no significant differences in the distribution and 
diversity of plasmids from early and late isolates of MRSA.
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Dice analysis of MRSA REFPs identified two main 
subgroups, FP1 and FP2. These groups correlated with 
sensitivity to aminoglycoside antibiotics.
Phage typing, biotyping and immunoblot analysis defined 
subgroups of MRSA which correlated well with each other, 
and with those defined by REFP analysis.
Significantly more aminoglycoside-sensitive MRSA 
produced enterotoxin, predominantly enterotoxin A, than 
their MSSA counterparts. Conversely most
aminoglycoside-resistant MRSA did not produce 
enterotoxins. These results concurred with the groupings 
defined by the various typing methods.
MRSA were more likely to produce multiple haemolysins 
than MSSA isolates. Aminoglycoside-sensitive and 
resistant MRSA were very similar with respect to 
haemolysin production, in contrast with enterotoxin 
production.
The results of antibiograms, biotyping, phage typing, 
immunoblotting, enterotoxin testing and REFPs were all 
compatible with the existence of 2 major clones of MRSA 
in GRI. The small plasmid data supported a hypothesis of 
local evolution of MRSA from endogenous MSSA.
APPENDIX 1
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Figure 22a. HaeIII restriction enzyme fragmentation patterns of
Staph, aureus; patterns (1-19).
30 -
Figure 22b. HaeIII restriction enzyme fragmentation patterns of
Staph, aureus; patterns (20-38).
30 -
Figure 22c. HaeIII restriction enzyme fragmentation patterns of
Staph, aureus; patterns (39-56).
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